gujarat technological university student list for m.pharm sem 4 … · 11-feb-19 172050825008 singh...

Date MAP_NUMBER Student_name sub codeBranch_C

ode

College_

Code

Branch_T

ypeBranch_name Micro Other_Micro DP1_TITLE Guide Name

11-Feb-19 172450829001 Chaudhary Rajat b MRW403P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED DOUBLE BLINDED, CROSS-

OVER BIOEQUIVALENCE STUDY OF

FELODIPINE EXTENDED RELEASE (10 MG)

TABLET UNDER FASTING CONDITION

DR. I. S. ANAND

11-Feb-19 172450829002 Chaudhary Shefali Jayantibhai MRW403P 29 245 MP Clinical PharmacyOTHER (KINDLY

SPECIFY)

ANTIBIOTIC SURVEY : PRESCRIBING

PATTERN, INCIDENCE OF SERIOUS ILLNESS

AND TOTAL LENGTH OF STAY IN ICU

PATIENTS.

DR. I. S. ANAND

11-Feb-19 172450829003Chaudhary Sumanben

RameshbhaiMRW403P 29 245 MP Clinical Pharmacy BABE STUDY

A RANDOMIZED CROSS-OVER

BIOEQUIVALENCE STUDY OF METOPROLOL

SUCCINATE EXTENDED RELEASE (200 MG)

TABLET UNDER FASTING CONDITION

DR. I. S. ANAND

11-Feb-19 172820829002 MONA HITESHKUMAR SUTHAR MRW403P 29 282 MP Clinical PharmacyOTHER (KINDLY

SPECIFY)

EVALUATION OF RATIONALITY OF

ANTIMICROBIAL AND ANTIDIARRHEAL FIX

DOSE COMBINATION USED IN INDIAN

POPLUTION

DR. HETAL D.

SOLANKI

11-Feb-19 172820829003PARMAR HEMAKSHIBEN

RAMANBHAIMRW403P 29 282 MP Clinical Pharmacy

OTHER (KINDLY

SPECIFY)

KNOWLEDGE AND PRACTICES OF

ANTIBIOTICS SELF-MEDICATION AMONG

HEALTHCARE PROFESSIONAL STUDENTS IN

GUJARAT

DR. HETAL D.

SOLANKI

11-Feb-19 152820806003 PATEL JINALI RAJESHBHAI 940106 06 282 MPCLINICAL

PHARMACY

CLINICAL STUDY, (CNS,

ARTHRITIS, CANCER,

EYES)

ASSESSMENT OF TOXICITY AND

TOLERABILITY OF IMRT BASED

CHEMORADIATION IN PATIENTS WITH

CARCINOMA CERVIX AT A RURAL BASED

COMMUNITY CANCER CENTRE IN INDIA

DR.UPAMA N

.TRIVEDI

11-Feb-19 172020826001 PATEL KAJAL DHANJIBHAI MRW403P 26 202 MP Pharmacognosy HERBAL RESEARCH

PHARMACOGNOSTICAL, PHYTOCHEMICAL

AND DIURETIC ACTIVITY OF RORIPPA

INDICA

DR.(MRS) MONA

KUKKAR

11-Feb-19 172120825007PATEL YASHIKAKUMARI

ISHWARBHAIMRW403P 25 212 MP Pharmacology BABE STUDY

BIOAVAILABILITY AND BIODISTRIBUTION

STUDY OF RIFAXIMIN CO-CRYSTALS IN RATSDR. RAVI A. MANEK

11-Feb-19 172130825004 NEMADE MRUNALI ASHOK MRW403P 25 213 MP Pharmacology BABE STUDY

COGNITION ASSESSMENT AMONG INDIAN

PATIENTS WITH HEAD AND NECK CANCER

USING PROMIS AND ICCTF RECOMMENDED

TESTS

DR. DEEPTI K. JANI

11-Feb-19 172130825005 PANDEY RASHI SURESHKUMAR MRW403P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF

FESOTERODINE FUMARATE PROLONGED

RELEASE TABLETS 8 MG IN FASTING

CONDITIONS

SANGEETHA L A

RAJBANSHI

11-Feb-19 172130825006PARMAR MOHINI

DHARMENDRASINHMRW403P 25 213 MP Pharmacology BABE STUDY

BIOEQUIVALENCE STUDY OF

FESOTERODINE FUMARATE PROLONGED

RELEASE TABLETS 8 MG IN FED

CONDITIONS

SANGEETHA L.A.

RAJBANSHI

Gujarat Technological University

Student list for M.Pharm Sem 4 (Regular) Research Week Exam (Summer 2019)GTU/S19/RW/MPH- 2993/779 Date:- 28-01-2019

11-Feb-19 172120825003 KUMBHANI MONIKA DHIRUBHAI MRW403P 25 212 MP Pharmacology

G.I. TRACT ( PLEASE

SPECIFY DISORDER OR

DISEASE)

EVALUATION OF THE EFFECT OF NELUMBO

NUCIFERA PLANT ON CHEMICAL INDUCED

ULCERATIVE COLITIS IN RATS

DR. JIGNESH I. PATEL

11-Feb-19 172120825004 MAHETAR NAFISA USMANBHAI MRW403P 25 212 MP Pharmacology

RESPIRATORY

DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ETHANOLIC EXTRACT OF

BOERHAAVIA DIFFUSA L. LEAVES ON

OVALBUMIN INDUCED ASTHMA MODEL


11-Feb-19 172120825008VAGHASIYA TRUPTI

PARSOTAMBHAIMRW403P 25 212 MP Pharmacology

RESPIRATORY

DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF EFFECT OF METHANOLIC

EXTRACT OF TERMINALIA CATAPPA L. IN

EXPERIMENTAL ANIMAL MODEL OF

ASTHMA

DR. DEVANG B.

SHETH

11-Feb-19 172390825001 RAJAWAT MAYANK PRAFUL MRW403P 25 239 MP Pharmacology

RESPIRATORY

DISORDER ( PLEASE

SPECIFY DISORDER OR

PHARMACOLOGICAL SCREENING OF FOUR

PROPIETARY POLYHERBAL FORMULATION

FOR THE TREATMENT OF COUGH.

MR. MITTAL DALAL

11-Feb-19 172390825004 TANDEL SHIVANI RAJESHBHAI MRW403P 25 239 MP Pharmacology EYE DISORDER

EFFECT OF ISOTINE®, ISOTINE PLUS® AND

ISOTINE GOLD® IN EXPERIMENTAL MODELS

OF CATARACT AND GLAUCOMA.

DR. ARINDAM PAUL

11-Feb-19 172680825003PATEL PINESHKUMAR

SURESHBHAIMRW403P 25 268 MP Pharmacology

RESPIRATORY

DISORDER ( PLEASE

SPECIFY DISORDER OR

EVALUATION OF ANTIASTHAMATIC

ACTIVITY OF ETHANOLIC EXTRACT OF

LUFFA ECHINATA ROXB. FRUITS

MR. VIPUL GAJERA

11-Feb-19 172120825001 GOHIL KIRAN KURJIBHAI MRW403P 25 212 MP PharmacologyOTHER (KINDLY

SPECIFY)

EVALUATION OF ANTI HEMOLYTIC ACTIVITY

OF ECLIPTA ALBA IN PHENYL HYDRAZINE

INDUCED ANEMIA IN RATS

DR. RAVI A. MANEK

11-Feb-19 172120825005MATHUR ANMOL

CHETENDRAKUMARMRW403P 25 212 MP Pharmacology

OTHER (KINDLY

SPECIFY)

EVALUATION OF ANTI-ARTHRITIC

POTENTIAL OF METHANOLIC EXTRACT OF

WHOLE PLANT OF BIOPHYTUM

SENSITIVUMIN FREUNDS ADJUVANT

INDUCED ARTHRITIS IN RATS


11-Feb-19 172120825009 VAGHELA UJJVAL PARESHBHAI MRW403P 25 212 MP PharmacologyOTHER (KINDLY

SPECIFY)

EFFECT OF ETHANOLIC EXTRACT OF

PUERARIA TUBEROSA (WILLD.)DC. TUBERS

IN LETROZOLE INDUCED POLYCYSTIC

OVARIAN SYNDROME (PCOS) IN RATS

DR. DEVANG B.

SHETH

11-Feb-19 172130825002 MAYUR WANKHADE MRW403P 25 213 MP PharmacologyOTHER (KINDLY

SPECIFY)

NUTRACEUTICAL INTERVENTIONS IN

PACLITAXEL- INDUCED NEUROPATHIC PAIN:

AN EXPERIMENTAL STUDY

DR. DEEPTI K. JANI

11-Feb-19 172390825003 SHAIKH UMAIRA ABDULRAKIB MRW403P 25 239 MP PharmacologyOTHER (KINDLY

SPECIFY)

ANTICOAGULANT AND ANTIHEMOLYTIC

ACTIVITY OF TECOMELLA UNDULATA -AN

EXPERIMENTAL STUDY

DR. ANKIT H MERAI

11-Feb-19 172680825002PARMAR POOJA

SURESHCHANDRAMRW403P 25 268 MP Pharmacology

OTHER (KINDLY

SPECIFY)

EVALUATION OF ANTI-ARTHRITIC ACTIVITY

OF BLUMEA BALSAMIFERA (L.) DC. IN

EXPERIMENTALLY INDUCED ARTHRITIS IN

RATS.

MR. VIPUL GAJERA

11-Feb-19 172280825002 DOBARIYA KOMAL MRW403P 25 228 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EVALUATE THE THERAPEUTIC POTENTIAL

OF CHRYSIN IN TYPE -2 DIABETES AND ITS

COMPLICATIONS

DR. ANITA A MEHTA

11-Feb-19 172280825003GORAKHIYA MONIKA

SHAILESHBHAIMRW403P 25 228 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

ASSESSMENT OF INSULIN EFFECT IN

HYPOTHYROIDISM AND OBESITY IN RATS

DR. MUSTAKIM M.

MANSURI

11-Feb-19 172050825001 Himanshi Ravinder Kaul MRW403P 25 205 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EVALUATION OF ANTI-OBESITY ACTIVITY OF

CORIANDRUM SATIVUM IN RAT MODELDR. TEJAL R. GANDHI

11-Feb-19 172050825003 NAIR KARISHMA JAYPRAKASH MRW403P 25 205 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EVALUATION OF NOX-4 INHIBITOR -

QUERCETIN IN 10 WEEKS RAT MODEL OF

DIABETIC NEPHROPATHY

DR. TEJAL R. GANDHI

11-Feb-19 172280825004 JAINEEL RAJESHBHAI DHAROD MRW403P 25 228 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EVALUATION OF ANTI-OBESITY EFFECT OF

BUPROPION AND L-HISTIDINE

COMBINATION IN HFD INDUCED OBESITY

IN MICE

DR. GAURANG B.

SHAH

11-Feb-19 172280825009YADAV RUCHIBEN

SHITALAPRASADMRW403P 25 228 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EFFECT OF GENISTEIN ON OVARIAN

FUNCTION IN HYPOTHYRODISED RAT

DR. MUSTAKIM M.

MANSURI

11-Feb-19 172390825002 SANAA ANSARI MRW403P 25 239 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EFFECT OF BAUHINIA PURPUREA AND

ANETHUM GRAVEOLENS ON

EXPERIMENTALLY INDUCED POLYCYSTIC

OVARY SYNDROME IN RATS.

DR. ARINDAM PAUL

11-Feb-19 172680825001MISTRY SHIVANGIBEN

NARESHKUMARMRW403P 25 268 MP Pharmacology

METABOLIC DISORDER

( PLEASE SPECIFY

DISORDER)

EVALUATION OF ANTIDIABETIC POTENTIAL

OF LUFFA ECHINATA ROXB. IN WISTAR

RATS

DR. VIJAY LAMBOLE

11-Feb-19 172120825002 GOL PRIYANKABEN RAMESHBHAI MRW403P 25 212 MP Pharmacology CNS DISORDER

EVALUATION OF ANTI PARKINSONIAN

ACTIVITY OF LANSOPRAZOLE IN ROTENONE

INDUCED RAT MODEL

DR. DEVANG B.

SHETH

11-Feb-19 172130825001 KUNDU SMITA SUMANKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDER

EVALUATION OF ACTIVITY OF LOXOPROFEN

IN VARIOUS ANIMAL MODELS OF

DEPRESSION

DR. DIGVIJAYSINH G.

RANA

11-Feb-19 172130825003 Mitra Pratik Sapan MRW403P 25 213 MP Pharmacology CNS DISORDER

EVALUATION OF ACTIVITY OF

TERIFLUNOMIDE IN VARIOUS ANIMAL

MODELS OF DEPRESSION

DR. DIGVIJAYSINH G.

RANA

11-Feb-19 172130825007 PATEL RUTU MANOJKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDER

EVALUATION OF ACTIVITY OF

MONTELUKAST IN VARIOUS ANIMAL

MODELS OF DEPRESSION

DR. DIGVIJAYSINH G.

RANA

11-Feb-19 172540825001CHAUHAN VATSALSINH

RAJENDRASINHMRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Operculina

turpethum root extract in scopolamine-

induced cognitive impairments in rats.

DR. PALLAVI K.J

11-Feb-19 172540825003 PARMAR JANHAVI ANILKUMAR MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of Anti-

inflammatory & Anti-nociceptive activities

of Doronicum hookeri root extract in rats

DR. PALLAVI K.J

11-Feb-19 172540825004 SHAIKH ZEBABIBI ZAHIR MRW403P 25 254 MP Pharmacology CNS DISORDER

pharmacological evaluation of

Antidepressant activity of Vigna radiata

seed extract in rats.

DR. PALLAVI K.J

11-Feb-19 172050825004 PATEL ANJALIBEN BIPINBHAI MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF SAPONIN RICH FRACTION

OF FOLK MEDICINES FOR THE TREATMENT

OF KIDNEY STONE DISEASES

DR. TEJAL R. GANDHI

11-Feb-19 172050825005 Patel Priyankaben Pankajbhai MRW403P 25 205 MP Pharmacology CVS DISORDER

CARDIOPROTECTIVE EFFECT OF

FOENICULUM VULGARE IN

ISOPROTERENOL INDUCED MYOCARDIAL

INFARCTION IN EXPERIMENTAL RATS

DR. TEJAL R. GANDHI

11-Feb-19 172050825006 Prajapati Riddhi Bansilal MRW403P 25 205 MP Pharmacology RENAL DISORDERS

EVALUATION OF FLAVANOID RICH

FRACTION OF FOLK MEDICINES IN

EXPERIMENTALLY INDUCED UROLITHIASIS

IN RAT MODEL

DR. TEJAL R. GANDHI

11-Feb-19 172050825007PUROHIT MILAP

DAKSHESHKUMARMRW403P 25 205 MP Pharmacology CVS DISORDER

CARDIOPROTECTIVE EFFECT OF

LANSOPRAZOLE IN EXPERIMENTALLY

INDUCED CARDIAC FIBROSIS

DR. SARIKA JOHARI

11-Feb-19 172050825008 SINGH ANJALI JEEVANKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDEREFFECT OF SERCA2 CHANNEL MODULATOR

ON DIABETIC CADIOMYOPATHY IN RATSDR. TEJAL R. GANDHI

11-Feb-19 172050825009 Vaibhav Hardikbhai Shah MRW403P 25 205 MP Pharmacology CVS DISORDER

PREPARATION AND EVALUATION OF

POLYHERAL FORMULATION FOR THE

TREATMENT OF DIABETIC

CARDIOMYOPATHY

DR. TEJAL R. GANDHI

11-Feb-19 172280825006 PURAV SUNILBHAI PATEL MRW403P 25 228 MP Pharmacology CVS DISORDER

EVALUATE THE EFFECT OF TLR-4

ANTAGONIST IN EXPERIMENTAL MODEL OF

MYOCARDIAL INFARCTION

DR. ANITA A MEHTA

11-Feb-19 172680825004 PATEL SHITALBEN RAJUBHAI MRW403P 25 268 MP Pharmacology

G.I. TRACT ( PLEASE

SPECIFY DISORDER OR

DISEASE)

EFFECT OF COMBINED EXTRACT OF CORDIA

DICHOTOMA FORST. AND AEGLE

MARMELOS CORR. IN EXPERIMENTAL

MODELS OF PEPTIC ULCER

DR. VIJAY LAMBOLE

11-Feb-19 172280825005KINJALKUMARI SUMANBHAI

GAMITMRW403P 25 228 MP Pharmacology

OTHER (KINDLY

SPECIFY)

FORMULATION OF PROBIOTIC CREAM AND

ITS EVALUATION IN DNFB INDUCED ATOPIC

DERMATITIS IN MICE

DR. GAURANG B.

SHAH

11-Feb-19 172280825007 Sangtani Kajol Haresh MRW403P 25 228 MP Pharmacology CNS DISORDER

ASSESSMENT OF THE RELATIONSHIP

BETWEEN ANTIDEPRESSANT AND

COGNITION IMPROVING ABILITIES OF

SHANKHPUSHPI AND ASHWAGANDHA

EXTRACTS IN MICE

DR. SUNITA

GOSWAMI

11-Feb-19 172280825008 Suthar Hiran Nilesh MRW403P 25 228 MP Pharmacology CNS DISORDER

EVALUATION OF WITHANIA SOMNIFERA

AND CONVOLVULUS PLURICAULIS (CHOISY)

IN SCHIZOPHRENIA INDUCED

IMPAIRMENTS IN VARIOUS COGNITIVE

DOMAINS USING SUB-CHRONIC PCP

MODEL IN RATS

DR. GAURANG B.

SHAH

11-Feb-19 172280825001 BHOOMIT MAHENDRABHAI PATEL MRW403P 25 228 MP Pharmacology CANCER

EFFECT OF DISULFIRAM AND CAFFEINE ON

NSCLC RESISTANCE TO GEMCITABINE AND

CISPLATIN

DR. SUNITA

GOSWAMI

11-Feb-19 172440825002 SHINDE AJAY PRAKASHBHAI MRW403P 25 244 MP Pharmacology CANCER

EVALUATION OF QUALITY OF LIFE AND

ECONOMIC IMPACT IN HEAD AND NECK

CANCER PATIENTS UNDERGOING

RADIOTHERAPY WITH OR WITHOUT

CONCURRENT CHEMOTHERAPY AT A

RURAL BASED CANCER CENTRE IN INDIA.

DR. SAMIR SHAH

12-Feb-19 172070820002 PANDYA KHYATIBEN NITINKUMAR MRW403P 20 207 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

“FORMULATION AND EVALUTION OF

BILAYERED BUCCAL TABLET OF IVABRADINE

HYDROCHLORIDE”

DR. VISHNU M.

PATEL

12-Feb-19 172070820003 patel yaminibahen nikhilkumar MRW403P 20 207 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

“FORMULATION AND EVALUTION OF

BUCCAL PATCH CONTAINING DULOXETINE

HYDROCHLORIDE FOR THE TREATMENT

OF DEPRESSION’’

DR. VISHNU M.

PATEL

12-Feb-19 172250820003 Patel Bhaveshkumar Amrutlal MRW403P 20 225 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND EVALUATION OF

BUCCAL FILMS OF PIRIBEDIL

DR. SHAILESH T.

PRAJAPATI

12-Feb-19 172250820006 PATEL RAJAT BHARATBHAI MRW403P 20 225 MP Pharmaceutics MULTIPARTICULATE


SUSTAINED RELEASE MICROSPHERES OF

ITOPRIDE HYDROCHLORIDE

DR. KEYUR S. PATEL

12-Feb-19 172470820009PANDIT VIPULKUMAR

DINESHKUMARMRW403P 20 247 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


BUCCAL FILMS OF SAXAGLIPTINMR. VIJAY K. PATEL

12-Feb-19 172780820005 SOLANKI ARTI NARENDRASINH MRW403P 20 278 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION DEVELOPMENT AND

EVALUATION OF BUCCAL TABLETS OF

ZOLPIDEM TARTRATE

DR. KINJAL SOLANKI

12-Feb-19 162470808006 PATEL VIJAYKUMAR JAYANTIBHAI 940102 08 247 MP PHARMACEUTICS

IR, ODT, DT,

SUBLINGUAL, FAST

DISPERSIBLE/DISSOLVI

NG


SUSTAINED RELEASE MATRIX TABLETS OF

PRAZOSIN HYDROCHLORIDE

MR.ANIL RAVAL

12-Feb-19 172450820001Chaudhary Jigneshkumar

IshwarbhaiMRW403P 20 245 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


FORMULATION AND OPTIMIZATION OF

ORODISPERSIBLE TABLET OF A SELECTIVE

APLPHA ADRENERGIC BLOCKING AGENT AS

NEFTOPIDIL

DR. H.D.KAREN

12-Feb-19 172470820002GAJERA KAUSHIKBHAI

GHANSHYAMBHAIMRW403P 20 247 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



ORODISPERSIBLE TABLETS OF

PALIPERIDONE

MR. ANIL G. RAVAL

12-Feb-19 172470820003 JOSHI ARJUN LALITBHAI MRW403P 20 247 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



SUBLINGUAL FILMS OF APIXABAN

DR. YOGESH K.

PATEL

12-Feb-19 172470820007 MEHTA HIR RAJIV KUMAR MRW403P 20 247 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EVALUATION OF GASTRORETENTIVE

FLOATING FILMS OF LAFUTIDINE

MR. VIJAY K. PATEL

12-Feb-19 172470820012SHAH AKASHKUMAR

NARESHKUMARMRW403P 20 247 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


COLON TARGETED PELLETS OF

BUMADIZONE CALCIUM

MR. ANIL G. RAVAL

12-Feb-19 172780820001 DALBANJAN NIKITA SURESHBHAI MRW403P 20 278 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



MOUTH DISSOLVING TABLETS OF

TELMISARTAN

DR. VIKRAM

PANDYA

12-Feb-19 172780820003 PANDIT MRUGESH SURESHBHAI MRW403P 20 278 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF FAST

DISSOLVING FILMS OF LINAGLIPTIN

DR. VIKRAM

PANDYA

12-Feb-19 172070820004 SHAH MONIKA NIKILKUMAR MRW403P 20 207 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



SUBLINGUAL TABLET OF HYDRALAZINE

HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL

12-Feb-19 172070820005Vadaliwala Munavvarbanu

AbdullatifMRW403P 20 207 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


DEVELOPMENT AND EVALUATION OF

ORODISPERSIBLE TABLET OF APIXABAN

DR. ANANDKUMAR

KANAIYALAL PATEL

12-Feb-19 172250820008 PATEL VRUNDABEN CHHGANBHAI MRW403P 20 225 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



SUBLINGUAL FILM OF IVABRADINE

HYDROCHLORIDE

DR. KEYUR S. PATEL

12-Feb-19 172470820001AGRAWAL HIMANSHU

GOPALBHAI MRW403P 20 247 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERISATION

AND IN VITRO DISSOLUTION

ENHANCEMENT OF AGOMELATION USING

SOLID DISPERSION METHOD

MR. VIJAY K. PATEL

12-Feb-19 172470820011PRAJAPATI KAJALBEN

ARVINDBHAIMRW403P 20 247 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


FORMULATION AND EVALUTION OF

ORALLY DISINTEGRATING TABLETS OF

MIRABEGRON

DR. DHARA B. PATEL

12-Feb-19 172470820013 SHARMA SUNNY SURESHBHAI MRW403P 20 247 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


CONTROLLED RELEASE OSMOTIC TABLET

OF CARVEDILOL PHOSPHATE

MR. ANIL G. RAVAL

12-Feb-19 172470820014TAPNIYA NILESHKUMAR

NATHABHAIMRW403P 20 247 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


FLOATING TABLETS OF FEBUXOSTAT

DR. YOGESH K.

PATEL

12-Feb-19 162250808015 PATEL ROMA BHARATKUMAR 940102 08 225 MP PHARMACEUTICS

IR, ODT, DT,

SUBLINGUAL, FAST


NG


ORALLY DISINTEGRATING TABLET OF

TRIMEPRAZINE

DR. SHAILESH T.

PRAJAPATI

12-Feb-19 172070820001 MANSURI AKIBBHAI YASINBHAI MRW403P 20 207 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT AND CHARACTERIZATION

OF CONTROLLED RELEASE MATRIX TABLET

OF TIAGABINE HYDROCHLORIDE

DR. ANANDKUMAR

KANAIYALAL PATEL

12-Feb-19 172250820002KANSAGARA AMEEBEN

RAMNIKBHAIMRW403P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


COLON TARGETED TABLETS OF

ELUXADOLINE

DR. SHAILESH T.

PRAJAPATI

12-Feb-19 172250820004PATEL JASMINABAHEN

VISHNUBHAIMRW403P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


SUSTAINED RELEASE MATRIX TABLETS OF

NATEGLINIDE

DR. SHAILESH T.

PRAJAPATI

12-Feb-19 172250820005PATEL NILESHKUMAR

MUKESHBHAIMRW403P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


GASTRORETENTIVE MUCOADHESIVE

TABLETS OF RANOLAZINE

DR. KEYUR S. PATEL

12-Feb-19 172250820007 PATEL SUMIT RAJESHBHAI MRW403P 20 225 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


FLOATING TABLETS OF PROPAFENONE

HYDROCHLORIDE

DR. KEYUR S. PATEL

12-Feb-19 172450820002 Vaghela Harshkumar Chamanlal MRW403P 20 245 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


SUSTAINED RELEASE TABLET OF NIFEDIPINEDR. P. H. PRAJAPATI

12-Feb-19 172470820004 KANANI MANISH BIPINBHAI MRW403P 20 247 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


GASTRORETENTIVE FLOATING IN-SITU GEL

OF ROSIGLITAZONE MALEATE

DR. YOGESH K.

PATEL

12-Feb-19 172520820001 BULA SANA MOHAMMADHUSAIN MRW403P 20 252 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


OF FLOATING-MUCOADHESIVE TABLET

CONTAINING QUETIAPINE FUMARATE

DR ALPESH D PATEL

12-Feb-19 172250824002 HIRAPARA FENIBEN JAYANTILAL MRW403P 24 225 MPPharmaceutical

Quality AssuranceSTABILITY STUDIES

STABILITY INDICATING HPLC METHOD

DEVELOPMENT AND VALIDATION OF

AMOXYCILLIN AND CLAVULANIC ACID IN

TABLET

Dr. SAMIR C. PATEL

12-Feb-19 172450824001 PATEL RITUBEN JASHVANTBHAI MRW403P 24 245 MPPharmaceutical


STABILITY STUDY OF SULTAMICILLIN AND

ITS TABLET FORMULATION UNDER

ACCELERATED AND STRESS CONDITION

DR. J. B. DAVE

12-Feb-19 172470824001ANSARI AFSHANNIKHAT

AQEELAHMEDMRW403P 24 247 MP

Pharmaceutical



STABILITY INDICATING RP-HPLC METHOD

FOR ESTIMATION OF SERTACONAZOLE

NITRATE AND BECLOMETHASONE

DIPROPIONATE IN CREAM

MS. ANKITA S. PATEL

12-Feb-19 172470824002DHARU NEETUKUMARI

RAJESHBHAIMRW403P 24 247 MP

Pharmaceutical




FOR SIMULTANEOUS ESTIMATION OF

NADIFLOXACIN AND CLOBETASOL

PROPIONATE IN CREAM

MS. KUNJAL L.

VEGAD

12-Feb-19 172470824003 HARDIK KIRTIKUMAR BHAVSAR MRW403P 24 247 MPPharmaceutical



STABILITY INDICATING ASSAY METHOD FOR

ESTIMATION OF TAMSULOSIN

HYDROCHLORIDE AND TOLTERODINE

TARTRATE IN CAPSULES

DR. VINAY C. DARJI

12-Feb-19 172470824008 PATEL RINKAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical



DEVELOPMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF

OXYCODONE HCL AND NALTREXONE HCL IN

CAPSULE

MR. KAUSHIK R.

PATEL

12-Feb-19 172470824011 PATIL POOJA SATISHBHAI MRW403P 24 247 MPPharmaceutical




FOR ESTIMATION OF MICONAZOLE

NITRATE AND HYDROCORTISONE IN CREAM

DR. VINAY C. DARJI

12-Feb-19 172470824012 Rathod Jinal Harshadkumar MRW403P 24 247 MPPharmaceutical





CLOTRIMAZOLE, CLINDAMYCIN PHOSPHATE

AND TINIDAZOLE CAPSULE

MR. JAYMIN G.

PATEL

12-Feb-19 172250824004 KACHCHHI RIDDHI RAMESHBHAI MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING

CHROMATOGRAPHIC METHOD


SERTACONAZOLE NITRATE AND ZINC

PYRITHIONE IN SHAMPOO

DR. DEEPA R. PATEL

12-Feb-19 172250824006 PATEL LAVINA GHANSHYAMBHAI MRW403P 24 225 MPPharmaceutical




DEVELOPMENT AND VALIDATION FOR THE


FLUCONAZOLE AND BECLOMETHASONE

DIPROPIONATE IN CREAM

DR. DEEPA R. PATEL

12-Feb-19 172470824004 MEGHA JINAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical


ANALYTICAL METHOD DEVELOPMENT AND

VALIDATION OF STABILITY INDICATING RP-

HPLC METHOD FOR ESTIMATION OF

BENIDIPINE HCL, TELMISARTAN AND

CHLORTHALIDONE IN TABLET

MS. ANKITA S. PATEL

12-Feb-19 172470824006PATEL DHARABEN

BHARATKUMARMRW403P 24 247 MP

Pharmaceutical





PARACETAMOL AND ZALTOPROFEN IN

TABLET

MR. KAUSHIK R.

PATEL

12-Feb-19 172470824007 PATEL POOJABEN AJAYBHAI MRW403P 24 247 MPPharmaceutical





BRINZOLAMIDE AND BRIMONIDINE

TARTRATE IN OPHTHALMIC SUSPENSION

DR. VINAY C. DARJI

12-Feb-19 172470824009 PATEL SEEMA NITINBHAI MRW403P 24 247 MPPharmaceutical





AMLODIPINE BESYLATE AND CELECOXIB IN

SYNTHETIC MIXTURE

MS. BHUMI R. PATEL

12-Feb-19 172470824010 PATEL UPASANA KANTILAL MRW403P 24 247 MPPharmaceutical





MEROPENEM AND VABORBACTAM IN

SYNTHETIC MIXTURE

MR. JAYMIN G.

PATEL

12-Feb-19 172470824015 VYAS KAJAL SHAILESHKUMAR MRW403P 24 247 MPPharmaceutical





FLUTICASONE FUROATE AND VILANTEROL

TRIFENATATE IN INHALATION POWDER

MS. ANKITA S. PATEL

12-Feb-19 172250824007 PATEL PINKI RANCHHODBHAI MRW403P 24 225 MPPharmaceutical





ENROFLOXACIN AND BROMHEXINE IN

COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

12-Feb-19 172250824008 SK MOTIUR RAHAMAN MRW403P 24 225 MPPharmaceutical





BETAHISTINE AND DOMPERIDONE IN


Dr. SAMIR C. PATEL

12-Feb-19 172250824009 VYAS RAMA SHIVKUMAR MRW403P 24 225 MPPharmaceutical


STABILITY INDICATING HPLC METHOD FOR

STIMULTANEOUS ESTIMATION OF

SERTACONAZOLE AND BECLOMETHASONE

IN THEIR COMBINED DOSAGE FORM

DR. DEEPA R. PATEL

12-Feb-19 172780824001 JANI KRUPA ASHWINKUMAR MRW403P 24 278 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


ANALYTICAL METHODS FOR THE


AMBROXOL HCL AND GUAIFENESIN IN

COMBINED PHARMACEUTICAL DOSAGE

FORM

DR RAJESH K PATEL

12-Feb-19 172780824004PATEL HARSHITKUMAR

PANKAJBHAIMRW403P 24 278 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


ANALYTICAL METHOD FOR THE


FLUCONAZOLE AND BECLOMETHAZONE

DIPROPIONATE IN COMBINED

PHARMACEUTICAL DOSAGE FORM

DR RAJESH K PATEL

12-Feb-19 172780824005 PATEL HINAL BALDEVBHAI MRW403P 24 278 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




DEXCHLOPHENIRAMINE MELEATE AND

BETAMETHASONE IN COMBINED


DR MITALI

SHRIMANKER

12-Feb-19 172780824007 SHAH SANKET NITINKUMAR MRW403P 24 278 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




TICLOPIDINE AND ASPIRIN IN COMBINED


DR RAJESH K PATEL

12-Feb-19 172060824010 Vadaliya Zaranaben kantibhai MRW403P 24 206 MPPharmaceutical

Quality AssuranceREGULATORY AFFAIRS

QUANTITATIVE COMPARISON BETWEEN

STANDARD AND GENERIC DRUG

CONTAINING PARACETAMOL,

ACECLOFENAC AND SERRATIOPEPTIDASE

BY RP-UPLC METHOD

DR. PRAGNESH

PATANI

12-Feb-19 172420824001BAGHEL LAXMI

SHIVNARAYANSINGHMRW403P 24 242 MP

Pharmaceutical


DOCUMENTATION IN QUALITY

MANAGEMENT SYSTEM (QMS) AND DATA

INTEGRITY IN PHARMACEUTICAL INDUSTRY

MS. JIGNA T. PATEL

12-Feb-19 172420824004 PATEL MINALBEN VINODBHAI MRW403P 24 242 MPPharmaceutical


A COMPREHENSIVE AND COMPARATIVE

STUDY ON REGULATIONS OF MEDICAL

COUNTERMEASURES IN USA, EUROPE AND

INDIA

DR. ANKIT B.

CHAUDHARY

12-Feb-19 172520824001 BHAVSAR DHRUV KAUSHIKBHAI MRW403P 24 252 MPPharmaceutical

Quality AssuranceBIOANALYTICAL

METHOD DEVELOPMENT AND VALIDATION

OF MESALAZINE IN HUMAN PLASMA BY LC-

MS/MS.

DR AMITKUMAR K

JOSHI

12-Feb-19 172600824005 PATEL AISHWARYA JITENDRA MRW403P 24 260 MPPharmaceutical

Quality AssuranceDISSOLUTION STUDIES


DISSOLUTION TEST METHOD FOR

FLUNARIZINE, DOMPERIDONE AND

PARACETAMOL IN PHARMACEUTICAL

DOSAGE FORM

DR. CHIRAG J. PATEL

12-Feb-19 172780824006 PUJARA DISHA KIRITKUMAR MRW403P 24 278 MPPharmaceutical


BIOANALYTICAL METHOD DEVELOPMENT

AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF AMBROXOL

HYDROCHLORIDE AND GUAIFENESIN IN

HUMAN PLASMA BY USING LC-MS/MS

DR KINJAL SOLANKI

12-Feb-19 172780824008THAKKAR BHOOMIBEN

HASMUKHBHAIMRW403P 24 278 MP

Pharmaceutical


BIO ANALYTICAL METHOD DEVELOPMENT

AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF SOFOSBUVIR AND

LEDIPASVIR IN HUMAN PLASMA BY LC-ESI-

MS/MS

DR RAJESH K PATEL

12-Feb-19 172280824002 DHAWAL KOTHARI MRW403P 24 228 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


VALIDATION FOR ESTIMATION OF

LORCASERIN HYDROCHLORIDE.

DR. ANURADHA

GAJJAR

12-Feb-19 172280824003 HAPPY PARIN PATEL MRW403P 24 228 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



CHROMATOGRAPHIC METHOD FOR

ESTIMATION OF ALFUZOSIN

HYDROCHLORIDE AND SOLIFENACIN

SUCCINATE IN THEIR COMBINED DOSAGE

FORM

DR. SINDHU EZHAVA

12-Feb-19 172780824002 JANI PRIYAL ASITBHAI MRW403P 24 278 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

EQUIPMENT QUALIFICATION OF BLISTER

PACKING MACHINE & ELECTRONIC CHECK

WEIGHER IPC 600

DR RAJESH K PATEL

12-Feb-19 172780824003KHATRI HEMAXI

DEVENDRAKUMARMRW403P 24 278 MP

Pharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

ANNUAL PRODUCT QUALITY REVIEW

(APQR) OF LOSARTAN TABLETS 100 MGDR VIKRAM PANDYA

12-Feb-19 172860824005 Pandya Shivangi Krupeshchandra MRW403P 24 286 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


ANALYTICAL METHODS FOR

DETERMINATION OF DILTIAZEM MELATE

AND ENALAPRIL MELATE FROM ITS FIXED

DOSE COMBINATION

DR. PINAK R. PATEL

12-Feb-19 172860824011 Shukla Rashmi Rammilan MRW403P 24 286 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



DETERMINATION OF RIVAROXABAN AND

ASPIRIN FROM SYNTHETIC MIXTURE.

DR. PINAK R. PATEL

12-Feb-19 172860824012 Sirsiker bhumi prashantbhai MRW403P 24 286 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



DETERMINATION OF TOBRAMYCIN AND

FLUOROMETHOLONE ACETATE FROM

OPTHALMIC FORMULATION

DR. PINAK R. PATEL

12-Feb-19 162520804003 PATEL JALAK VINUBHAI 940104 04 252 MPQUALITY

ASSURANCESTABILITY STUDIES


STABILITY INDICATING HPLC METHOD FOR


BENIDIPINE HCI AND CHLORTHALIDONE IN

TABLET

MR M L KHARODIYA

12-Feb-19 172280824006 Shah Jaldhi Hemantbhai MRW403P 24 228 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


STABILITY INDICATING METHOD FOR

ESTIMATION OF DAPAGLIFLOZIN AND ITS

APPLICATION TO STUDY DEGRADATION

KINETICS

DR. KUNJAN

BODIWALA

12-Feb-19 172280824007 SHAH PRIYAL KALPESHKUMAR MRW403P 24 228 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



EFONIDIPINE HYDROCHLORIDE

ETHANOLATE

DR. ANURADHA

GAJJAR

12-Feb-19 172420824003MANGROLIYA RUCHITA

HIMMATBHAIMRW403P 24 242 MP

Pharmaceutical

Quality AssurancePROCESS VALIDATION

PROSPECTIVE PROCESS VALIDATION OF

ANTIINFLAMMATORY (CORTICOSTEROID)

INJECTION SUSPENSION USP 40 MG/ML

DR. ANKIT B.

CHAUDHARY

12-Feb-19 172470824013 Salunkhe Suchitra Sunil MRW403P 24 247 MPPharmaceutical


PROCESS VALIDATION OF RIFAMPICIN AND

ISONIAZID FILM COATED TABLETS

MR.JAYMIN G.

PATEL

12-Feb-19 172470824014 VAGH VIRAL VITTHALBHAI MRW403P 24 247 MPPharmaceutical


PROCESS OPTIMIZATION AND PROCESS

VALIDATION OF MYOINOSITOL AND D-

CHIRO INOSITOL FILM COATED TABLET

MS. BHUMI R. PATEL

12-Feb-19 172600824007 THAKKER KRINA SURESHKUMAR MRW403P 24 260 MPPharmaceutical


PROCESS VALIDATION OF OPTIMIZED

FORMULATION OF VENLAFAXINE

HYDROCHLORIDE 37.5 MG TABLET DOSAGE

FORM

DR. CHIRAG J. PATEL

12-Feb-19 172860824013 Vasani Priyanka sureshbhai MRW403P 24 286 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



DETERMINATION OF PAMABROM AND

NSAIDs IN COMBINATION

DR. PINAK R. PATEL

12-Feb-19 162470804013 patel nikita mahendrabhai 940104 04 247 MPQUALITY

ASSURANCE




TICLOPIDINE AND ASPIRIN IN ITS


Mr.Jaymin G.Patel

12-Feb-19 172250824003 JAIN JUHI ANILKUMAR MRW403P 24 225 MPPharmaceutical





BENIDIPINE HYDROCHLORIDE AND


DR. DEEPA R. PATEL

12-Feb-19 172250824001 Dhruv Nikita Mahendrakumar MRW403P 24 225 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF HPLC

METHOD FOR SIMULTANEOUS ESTIMATION

OF BENIDIPINE HCL, TELMISARTAN AND

CHLORTHALIDONE IN TABLET DOSAGE

FORM

DR. DEEPA R. PATEL

12-Feb-19 172250824005 PANCHAL HINABEN HASUBHAI MRW403P 24 225 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



TRIHEXYPHENIDYL, THIORIDAZINE AND

TRIFLUOPERAZINE IN ITS PHARMACEUTICAL

DOSAGE FORM BY HPLC

DR. DEEPA R. PATEL

13-Feb-19 172020820002 Vashi Janu Alkeshkumar MRW403P 20 202 MP Pharmaceutics MULTIPARTICULATE


ILEO-COLONIC TARGETED MUCOADHESIVE

MICROSPHERES CONTAINING

FLURBIPROFEN FOR TREATMENT OF

ULCERATIVE COLITIS

DR. SAIKAT PANDE

13-Feb-19 172050820001 Joshi Deepika Manohar MRW403P 20 205 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FABRICATION AND IN VITRO EVALUATION

OF FEBUXOSTAT TABLET FOR OBTAINING

BIPHASIC DRUG RELEASE PROFILE

DR. MUKESH GOHEL

13-Feb-19 172050820005 PATEL KAJOLBEN ARUNKUMAR MRW403P 20 205 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

PREPARATION AND CHARACTERIZATION OF

TOPICAL FORMULATION CONTAINING

QUERCETIN AS WOUND HEALING

PHYTOPHARMACEUTICAL

DR. VAISHALI

THAKKAR

13-Feb-19 172050820009 Udhwani Nikita Haresh MRW403P 20 205 MP Pharmaceutics MULTIPARTICULATE

EXPLORATION OF RESEARCH

OPPORTUNITIES IN THE DEVELOPMENT OF

IMMEDIATE RELEASE MINI-TABLETS OF

CILOSTAZOL

DR. MUKESH C.

GOHEL

13-Feb-19 172050820010 Vyas Shubham Sanjaykumar MRW403P 20 205 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


OF ROXITHROMYCIN TOPICAL GEL

DR. VAISHLAI

THAKKAR

13-Feb-19 172130820007 SHAH HARDIK SANJAYKUMAR MRW403P 20 213 MP PharmaceuticsVESICULAR DRUG

DELIVERY SYSTEM

DEPOFOAM TECHNOLOGY BASED

INTRAMUSCULAR DRUG DELIVERY OF

PREDNISOLONE ACETATE FOR TREATMENT

OF RHEUMATOID ARTHRITIS

DR.PRACHI PANDEY

13-Feb-19 172230828002 KAPADIA DHWANI PREYAS MRW403P 28 223 MPPharmaceutical

Technology

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

FORMULATION AND CHARACTERIZATION

OF LIPOSOME BASED INTRA-NASAL

DELIVERY OF ARIPIPRAZOLE

DR. ALIASGAR J

KUNDAWALA

13-Feb-19 172020820001PATEL VISHAKHAKUMARI

MAHESHKUMARMRW403P 20 202 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO

N, SEDDS, LIPID BASED

DDS

SOLID SELF NANOEMULSIFYING DRUG

DELIVERY SYSTEM: A NOVEL APPROACH

FOR THE ORAL ADMINISTRATION OF

POORLY WATER SOLUBLE DRUG

DR. AJAY SOLANKI

13-Feb-19 172050820002 MALAV RUPESH MANIAR MRW403P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

DEVELOPMENT, CHARACTERIZATION AND

EVALUATION OF DIBASIC CALCIUM

PHOSPHATE DIHYDRATE FOR THE

FORMULATION OF SOLID ORAL DOSAGE

FORM

DR. MUKESH GOHEL

13-Feb-19 172050820011 MS. PAROMITA SAHA MRW403P 20 205 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

MINIMIZATION OF RETARDATION OF DRUG

RELEASE FROM HARD GELATIN CAPSULE

DR. MUKESH C.

GOHEL

13-Feb-19 172130820004 PATEL DHRUVI KAMLESHBHAI MRW403P 20 213 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT


SPRAY DRIED SOLID DISPERSION OF AN

ANTI-DIABETIC DRUG FOR DISSOLUTION

ENHANCEMENT

DR. NAAZNEEN

SURTI

13-Feb-19 172350820001 Bariya Hiralbhai Ranchhodbhai MRW403P 20 235 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT


CHARACTERIZATION OF DIRECTLY

COMPRESSIBLE TABLETS OF NISOLDIPINE

LOADED SPHERICAL CRYSTAL

AGGLOMERATES

DR. HITESH JAIN

13-Feb-19 172350820002 Dindod Swetalben Babubhai MRW403P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN AND CHARACTERIZATION OF

MICROSPONGE LOADED CONTROLLED

RELEASE TOPICAL GEL OF LULICONAZOLE

DR. HITESH JAIN

13-Feb-19 172350820003 NEHATE SHWETA BHAGWAN MRW403P 20 235 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


OPTIMIZATION OF MUCOADHESIVE IN SITU

NASAL GEL CONTAINING MONTELUKAST

SODIUM

DR. HITESH JAIN

13-Feb-19 172050820008 Tadvi Gaureeben Rajeshbhai MRW403P 20 205 MP PharmaceuticsOTHER (KINDLY

SPECIFY)

DEVELOPMENT OF DISINTEGRATION

CONTROLLED MATRIX TABLET OF

GLIBENCLAMIDE

MS. DIPIKA CHAVDA

13-Feb-19 172130820001 KM SHALINI SHARMA MRW403P 20 213 MP PharmaceuticsOTHER (KINDLY

SPECIFY)

CYCLODEXTRIN BASED NANOSPONGES: AN

EFFECTIVE METHOD FOR DISSOLUTION

ENHANCEMENT OF LOW SOLUBILITY

NUTRACEUTICAL

DR ASHOK

MAHAJAN

13-Feb-19 172130820002 MISTRY JHEEL RAJUBHAI MRW403P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


NANOEMULSION BASED IN-SITU GEL FOR

OCULAR DRUG DELIVERY OF ACECLOFENAC

DR.PRIYAL PATEL

13-Feb-19 172130820005PATEL VAISHNAVIBEN

PRAVINBHAIMRW403P 20 213 MP Pharmaceutics

OTHER (KINDLY

SPECIFY)

VAGINAL DRUG DELIVERY SYSTEM OF

METHOTREXATE FOR TREATMENT OF

RHEUMATOID ARTHRITIS

DR. NAAZNEEN

SURTI

13-Feb-19 172130820008 TELI ANJALIBEN KUSHALCHANDRA MRW403P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT OF TARGETED

FORMULATION OF BUDESONIDE FOR

INFLAMMATORY BOWEL DISEASE

MANAGEMENT

DR. MANISHA S.

LALAN

13-Feb-19 172130820009 TRIVEDI RUSHI JAWAHARLAL MRW403P 20 213 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


INTRANASAL IN-SITU GEL OF PRAMIPEXOLE

DIHYDROCHLORIDE

DR.MEENAKSHI

PATEL

13-Feb-19 172230828001 DESAI ANJALI DATTATRAY MRW403P 28 223 MPPharmaceutical

Technology

OTHER (KINDLY

SPECIFY)


SPRAY DRIED INHALABLE DRY POWDER OF

POSACONAZOLE FOR PULMONARY

ASPERGILLOSIS

DR. ALIASGAR J

KUNDAWALA

13-Feb-19 172440820003 PATEL RIKIN RAMESH MRW403P 20 244 MP PharmaceuticsOTHER (KINDLY

SPECIFY)

FORMULATION, DEVELOPMENT AND

EVALUATION OF MEDICATED CHEWING

GUM OF AVANAFIL

M. RAHIL G. BHURA

13-Feb-19 172050820003 Panchal Punam Ketankumar MRW403P 20 205 MP Pharmaceutics MISCELANEOUS


GLIPIZIDE PASTILLES BY EMPLOYING

QUALITY BY DESIGN APPROACH

MR. HARDIK RANA

13-Feb-19 172050820004 Patel Ashviniben Dilipbhai MRW403P 20 205 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


DEVELOPMENT AND OPTIMIZATION OF

ORAL SPRAY OF TADALAFIL EMPLOYING

QbD APPROACH

MR. HARDIK RANA

13-Feb-19 172050820006 Raut Jignasaben Devrambhai MRW403P 20 205 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


DISSOLUTION ENHANCEMENT OF

BOSWELLIA SERRATA EXTRACT BY

LIQUISOLID APPROACH

MS. DIPIKA

CHAVADA

13-Feb-19 172050820007 Tadvi Arunaben Kanchanbhai MRW403P 20 205 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



BICALUTAMIDE BY DEVELOPING SOLID

DISPERSION EMPLOYING MICROWAVE

OVEN

DR. VAISHALI T.

THAKKAR

13-Feb-19 172130820003 NAZIYA ILYAS GHEEWALA MRW403P 20 213 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


SPRAY DRIED SOLID DISPERSION : AN

EFFICIENT METHOD FOR DISSOLUTION

ENHANCEMENT OF NEVIRAPINE

DR ASHOK

MAHAJAN

13-Feb-19 172130820006 PATEL VRUNDA SANJAYKUMAR MRW403P 20 213 MP Pharmaceutics MISCELANEOUS

PREPARATION AND EVALUATION OF DRY

POWDER INHALER FORMULATION FOR

PULMONARY DELIVERY OF CEFTAZIDIME.

DR.PRIYAL PATEL

13-Feb-19 172440820001 DARJI JIGNESHBHAI MUKESHBHAI MRW403P 20 244 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



MEDICATED CHEWING GUM OF

RALOXIFENE HYDROCHLORIDE

MR. MEHUL B. VYAS

13-Feb-19 172020824001 PATEL TWINCYBEN KIRITBHAI MRW403P 24 202 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


STABILITY INDICATING HPTLC METHOD FOR

PERAMPANEL IN IT’S TABLET DOSAGE

FORM

DR. RAJENDRA

MEHTA

13-Feb-19 172050824004 PATEL KRISHNA SURESHBHAI MRW403P 24 205 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



TADALAFIL AND DAPOXETINE

HYDROCHLORIDE IN NEWER COMBINED

DOSAGE FORM USING QBD APPROACH

DR. PURVI A. SHAH

13-Feb-19 172050824006 Shah Nejal Nitinkumar MRW403P 24 205 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


ANALYTICAL METHOD FOR

QUANTIFICATION OF NEPAFENAC IN

NEWER OPTIMIZED OPHTHALMIC

FORMULATION

DR. KALPANA G.

PATEL

13-Feb-19 172130824008UPADHYAY KHYATIBEN

VIJAYKUMARMRW403P 24 213 MP

Pharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


LIQUID CHROMATOGRAPHIC METHOD FOR

ESTIMATION OF FIMASARTAN POTASSIUM

TRIHYDRATE IN PRESENCE OF ITS RELATED

SUBSTANCES

DR. DIMAL SHAH

13-Feb-19 172230823002 Patel Keshaben Manojbhai MRW403P 23 223 MPPharmaceutical

Analysis

OTHER (KINDLY

SPECIFY)



QUANTIFICATION OF MACITENTAN IN BULK

AND PHARMACEUTICAL DOSAGE FORM

DR. USMANGANI K.

CHHALOTIYA

13-Feb-19 172230823003YADAV PREETIBEN

NARESHKUMARMRW403P 23 223 MP

Pharmaceutical

Analysis

OTHER (KINDLY

SPECIFY)


CHROMATOGRAPHIC AND UV-VISIBLE

SPECTROSCOPIC METHODS FOR

QUANTIFICATION OF MIRABEGRON IN

BULK AND PHARMACEUTICAL DOSAGE

FORM

DR. USMANGANI K.

CHHALOTIYA

13-Feb-19 172460824004 PRACHI GUPTA MRW403P 24 246 MPPharmaceutical

Quality Assurance

QUALITY RISK

MANAGEMENT

A SYSTEMATIC APPROACH TO NEW

PRODUCT INTRODUCTION WITH

EMPHASIS ON THE CONTAINMENT

STRATEGIES AND QUALITY RISK

MANAGEMENT

DR ANKITA

BHAVSAR

13-Feb-19 172460824005SONI FALAKKUMAR

SUBHASHCHANDRAMRW403P 24 246 MP

Pharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

FORMULATION AND ANALYTICAL METHOD

DEVELOPMENT OF IVACAFTOR

CONTAINING PHARMACEUTICAL DOSAGE

FORM

DR ANKITA

BHAVSAR

13-Feb-19 172020824002THESIYA KRISHNABEN


Pharmaceutical


DEVELOPMENT & VALIDATION OF


FOR RIOCIGUAT IN TABLET DOSAGE FORM

DR.(MRS)

ANANDKUMARI D

CAPTAIN

13-Feb-19 172130824001 JOSHI KRUPABEN PRAVINBHAI MRW403P 24 213 MPPharmaceutical




ESTIMATION OF FLIBANSERIN IN THE

PRESENCE OF ITS RELATED SUBSTANCE

DR. FALGUN A.

MEHTA

13-Feb-19 172130824003 NAIR SHREYA RADHAKRISHNAN MRW403P 24 213 MPPharmaceutical


DEVELEOPMENT AND VALIDATION OF


ESTIMATION OF POLMACOXIB IN PRESENCE

OF ITS RELATED SUBSTANCES.

DR. FALGUN A.

MEHTA

13-Feb-19 172130824004 PANCHAL PRACHI VISHNUKUMAR MRW403P 24 213 MPPharmaceutical




ESTIMATION OF NETUPITANT IN THE

PRESENCE OF ITS RELATED SUBSTANCE

DR. FARHATJAHAN

SHAIKH

13-Feb-19 172460824001CHAUDHARI URVASHIBEN

ANILKUMARMRW403P 24 246 MP

Pharmaceutical


STABILITY INDICATING ANALYTICAL

METHOD DEVELOPMENT AND

VALIDATION FOR SIMULTANEOUS

ESTIMATION OF ENROFLOXACIN AND

BROMHEXINE HCL IN BULK AND


DR ANKITA

BHAVSAR

13-Feb-19 172460824002 DESAI PAMIL SHAMJIBHAI MRW403P 24 246 MPPharmaceutical



STABILITY INDICATING METHOD FOR

ESTIMATION OF RIOCIGUAT IN BULK AND


DR ANKITA

BHAVSAR

13-Feb-19 172050824002Chunara Kiranben

Rameshchandra MRW403P 24 205 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




EMPAGLIFLOZIN AND METFORMIN

HYDROCHLORIDE IN NEWER

PHARMACEUTICAL FORMULATION

DR. PURVI A. SHAH

13-Feb-19 172050824003 DESAI JINAL HEMANTKUMAR MRW403P 24 205 MPPharmaceutical

Quality AssuranceHERBAL


ANALYTICAL METHOD FOR ESTIMATION OF

BERBERINE AND RETINOIC ACID IN NOVEL

HERBAL FORMULATION USING

EXPERIMENTAL DESIGN

DR.KALPANA G.

PATEL

13-Feb-19 172050824007 Shah Nischay Sunil MRW403P 24 205 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


ANALYTICAL METHOD DEVELOPMENT FOR

FLUCONAZOLE AND QUERCETIN IN NOVEL

TOPICAL GEL FORMULATION

MR. HITESH G.

RAVAL

13-Feb-19 172130824002MIRZA NILAMFATEMA

MOHAMMADASKARIMRW403P 24 213 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




PITAVASTATIN CALCIUM AND EZETIMIBE

FROM ITS COMBINED TABLET DOSAGE

FORM

DR. VANDANA B.

PATEL

13-Feb-19 172130824005 PARMAR PAYAL MAHESHBHAI MRW403P 24 213 MPPharmaceutical



ANALYTICAL METHODS FOR ESTIMATION

OF VALBENAZINE TOSYLATE IN BULK

DR. VANDANA B.

PATEL

13-Feb-19 172130824006 PRAJAPATI DHRUVI ANILKUMAR MRW403P 24 213 MPPharmaceutical

Quality AssuranceIMPURITY PROFILING

DEVELOPMENT AND VALIDATION OF RP-

HPLC METHOD FOR ANALYSIS OF

ALOGLIPTIN BENZOATE IN THE PRESENCE

OF ITS RELATED SUBSTANCES

DR. SHAILESH

KORADIA

13-Feb-19 172130824007 TAHILRAMANI POOJA JAGDISH MRW403P 24 213 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF UV

AND CHROMATOGRAPHIC METHODS FOR

ESTIMATION OF MIRABEGRON AND

SOLIFENACIN SUCCINATE IN COMBINATION

DR. DIMAL SHAH

13-Feb-19 172150827001BHANDARI KRISHNA

KAUSHIKKUMARMRW403P 27 215 MP

Pharmaceutical

Regulatory AffairsREGULATORY AFFAIRS

CURRENT REGULATORY REQUIREMENT FOR

EXPORT OF SOLID ORAL DOSAGE FORM IN

BRAZIL AND MEXICO

DR .VINEET JAIN

13-Feb-19 172150827002Chaudhary Reena

BhagawanswaroopMRW403P 27 215 MP

Pharmaceutical


GUIDELINES AND REGULATORY

REQUIREMENTS FOR LABELLING AND

PACKAGING OF INJECTIONS IN USA,

EUROPE, INDIA AND CANADA.

DR. RONAK

DEDANIA

13-Feb-19 172880827001 Ansari Daraksha Muhammad MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS FOR

MOISTURIZING CREAM AND ANTIACNE

CREAM IN INDIA, USA, EUROPEAN UNION

COUNTRIES, TANZANIA AND ETHIOPIA

MR. FENIL SHAH

13-Feb-19 172880827002 BATADA NORIN BARKATBHAI MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY

REQUIREMENTS AS PER USFDA & EMA FOR

IMMEDIATE RELEASE AND EXTENDED

RELEASE ORAL FORMULATIONS AND

COMPILATION OF MODULE 3 AND 5 AS PER

EMA

MR. NAGESH

NANDA

13-Feb-19 172880827003DEVADHA MEHULBHAI

RAJNIKANTMRW403P 27 288 MP

Pharmaceutical


REGISTRATION OF AMLODIPINE TABLET IN

USA & EU COUNTRIES AND IMPLICATIONS

FOR CHANGE IN EXCIPIENT

CONCENTRATION

DR. RAJESH PARIKH

13-Feb-19 172880827004 GANDHI HANSAL VIJAY MRW403P 27 288 MPPharmaceutical


A STUDY ON REGISTRATION PROCESS OF

GENERIC BUDESONIDE DRY POWDER

INHALER AS PER USFDA GUIDANCE

DR. RAJESH PARIKH

13-Feb-19 172150827003 Dobariya Janki Rasikkumar MRW403P 27 215 MPPharmaceutical

Regulatory Affairs

SIMULTENEOUS

ESTIMATION

A COMPREHENSIVE STUDY ON

REGULATORY REQUIREMENTS FOR

PRODUCT REGISTRATION OF VACCINES IN

USA, EUROPE AND CANADA.

DR. RONAK

DEDANIA

13-Feb-19 172150827004 Juneja Parul jitender MRW403P 27 215 MPPharmaceutical


REGULATORY GUIDELINES OF HAZARD

ANALYSIS CRITICAL CONTROL POINT

(HACCP) WITH COMPREHENSIVE STUDY ON

STANDARDS AND CERTIFICATION

PROCEDURES IN USA, AUSTRALIA AND

INDIA IN RELEVANCE TO PHARMA

INDUSTRY

DR. RONAK

DEDANIA

13-Feb-19 172150827005 MAHLA SWETA MAVJIBHAI MRW403P 27 215 MPPharmaceutical


A COMPARATIVE STUDY OF REGULATORY

REQUIREMENTS AND GUIDELINES FOR

MEDICAL DEVICES IN USA,JAPAN AND

CANADA

DR. RONAK

DEDANIA

13-Feb-19 172150827008 TAILOR BRINDA ASHISHKUMAR MRW403P 27 215 MPPharmaceutical


CURRENT STATUS OF GENERIC DRUG

APPROVAL PROCESS IN UNITED STATES OF

AMERICA AND EUROPEAN UNION

DR .VINEET JAIN

13-Feb-19 172150827009YADAV KUSUM KUMARI SHREE

DINESH KUMARMRW403P 27 215 MP

Pharmaceutical


NAVIGATING REGULATORY FRAMEWORK

TO DEFEAT ZIKA VIRUS IN USA AND EUDR .VINEET JAIN

13-Feb-19 172880827005 GOHEL SAGAR KISHORBHAI MRW403P 27 288 MPPharmaceutical


A STUDY ON SUMMARY TECHNICAL

DOCUMENTATION (STED) FOR

TRANSCATHETER SEPTAL OCCLUDER AS PER

INTERNATIONAL MEDICAL DEVICE

REGULATORS FORUM (IMDRF)

DR. ANAND SHAH

13-Feb-19 172880827008 PATEL PANKTIBEN KIRTIKUMAR MRW403P 27 288 MPPharmaceutical


COMPARISON OF REGULATORY

REQUIREMENTS AS PER USFDA & EMA FOR

DELAYED RELEASE AND EXTENDED RELEASE

ORAL FORMULATIONS AND COMPILATION

OF MODULE 3 AND 5 AS PER EMA

MR. KASHYAP

THUMMAR

13-Feb-19 172880827009PATEL YAGNESHKUMAR

VINODBHAIMRW403P 27 288 MP

Pharmaceutical


A STUDY ON REGISTRATION PROCESS OF

RITUXIMAB INJECTION -A BIOSIMILAR

PRODUCT TO MabThera® AS PER EMA

MR. FENIL SHAH

13-Feb-19 172880827010 Shipra Vijayesh Pandey MRW403P 27 288 MPPharmaceutical


NALOXONE HCL NASAL SPRAY : DRAFT

DOSSIER PREPARATION FOR ANDS AS PER

HEALTH CANADA

DR. ANAND SHAH

13-Feb-19 172880827006 JADAV RAHUL KIRITKUMAR MRW403P 27 288 MPPharmaceutical


A STUDY ON REGULATORY REQUIREMENTS

TO PREVENT COUNTERFEIT DRUGS IN USA,

EUROPE & INDIA

MR. NIRAV CHOKSHI

13-Feb-19 172880827007JAGANI DHARMESHKUMAR

UKABHAIMRW403P 27 288 MP

Pharmaceutical


PREPARATION OF DRAFT ABBREVIATED

NEW DRUG APPLICATION (ANDA) FOR

OSELTAMIVIR CAPSULE AS PER USFDA

DR. ANAD SHAH

13-Feb-19 172880827011THAKKAR RAGHAV

ATMARAMBHAIMRW403P 27 288 MP

Pharmaceutical


REGULATORY CONSIDERATION FOR

IMPORT & REGISTRATION OF

HEMODIALYSER IN INDIA & EXPORT IN

MEMBER COUNTRIES OF ASEAN

MR. KASHYAP

THUMMAR

12-Feb-19 172820824001 PATEL BIRAJKUMAR VIJAYBHAI MRW403P 24 282 MPPharmaceutical




FOR FLUCONAZOLE AND

BECLOMETHASONE IN ITS COMBINED

DOSAGE FORM

DR. M.B. SHANKAR

12-Feb-19 172820824002 PATEL SUNNY HEMANTKUMAR MRW403P 24 282 MPPharmaceutical



LIQUID CHROMATOGRAPHIC METHOD FOR


DOXOPHYLLINE AND ACEBROPHYLLINE IN

BULK AND COMBINED DOSAGE FORM.

DR. M.B.SHANKAR

12-Feb-19 172820824004RATHAVA ATULBHAI

JAGDISHBHAIMRW403P 24 282 MP

Pharmaceutical




FOR ESTIMATION OF ULIPRISTAL ACETATE

IN ITS BULK AND DOSAGE FORM

DR. M.B. SHANKAR

12-Feb-19 172820824005 SUTHAR ROSHAN JAGADISHBHAI MRW403P 24 282 MPPharmaceutical


DEVELOPMENT AND VALIDATION OF HPTLC

METHOD FOR ESTIMATION OF

EFONIDIPINE HYDROCHLORIDE

ETHANOLATE IN BULK AND


DR. M.B.SHANKAR

14-Feb-19 172120820002 BHATT UKTI JANAKBHAI MRW403P 20 212 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

STUDIES IN APPLICATION OF HOT MELT

EXTRUSION TECHNIQUE FOR

DEVELOPMENT OF DELAYED RELEASE

FENOFIBRATE WITH IMPROVED

DISSOLUTION.

DR S R SHAH

14-Feb-19 172120820005CHUDASAMA TARUN

RAMESHBHAIMRW403P 20 212 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EXTENDED RELEASE TABLET OF NIACIN.DR J R CHAVDA

14-Feb-19 172120820006 GELHOR HIMANI BABUBHAI MRW403P 20 212 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


SUSTAINED RELEASE FLOATING TABLET OF

CINNARIZINE.

DR D R BHIMANI

14-Feb-19 172670828001 PATEL BHUMI BHARAT MRW403P 28 267 MPPharmaceutical

Technology

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


MUCOADHESIVE MICROEMULSION OF

RESVERATROL FOR NOSE TO BRAIN

DELIVERY IN TREATMENT OF ALZHEIMER

DISEASE

DR. PRAKASH

SUKHRAMANI

14-Feb-19 172690820001 Bhuva Mitalben Dineshbhai MRW403P 20 269 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN, FORMULATION AND EVALUATION

OF PRESS COATED PULSATILE DRUG

DELIVERY SYSTEM OF AZILSARTAN

MEDOXOMIL TABLET

SHEETAL

BUDDHADEV

14-Feb-19 172690820002PANKHANIYA HIMANSU

PRAVINBHAIMRW403P 20 269 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION, EVALUATION AND

OPTIMIZATION OF SUSTAINED RELEASE

DRUG DELIVERY SYSTEM OF CISAPRIDE

TABLET

RAM DARSHIT

14-Feb-19 172690820004 Raninga Tushar Kishorbhai MRW403P 20 269 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN, DEVELOPMENT AND EVALUTION

OF BILAYER TABLET OF PIOGLITAZONE AND

PHENFORMIN FOR EXTENDED RELEASE

SYSTEM

SHEETAL

BUDDHADEV

14-Feb-19 172120820003 BHOLA JAYDIPKUMAR HAJABHAI MRW403P 20 212 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


LIQUISOLID TABLET OF EFAVIRENZ FOR

IMPROVING DISSOLUTION

CHARACTERISTICS: DESIGN, DEVELOPMENT

AND OPTIMIZATION

DR. M. M.

SONIWALA

14-Feb-19 172120820007 makvana vaghabhai dulabhai MRW403P 20 212 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


SOLID DISPERSION AS AN APPROACH FOR


DARUNAVIR.

DR M M SONIWALA

14-Feb-19 172120820010 PATEL JETALBEN VASANTBHAI MRW403P 20 212 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


MEDICATED CHOCOLATE CONTAINING

CEFIXIME TRIHYDRATE: A NOVEL SOLID

DOSAGE FORM FOR PEDIATRIC PATIENTS.

K A PATEL

14-Feb-19 172640820003 GADHVI SIDDHI SANJAYDAN MRW403P 20 264 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


FORMULATION AND EVALUATION OF ORO

DISPERSIBLE TABLETS OF ONDANSETRON

HYDROCHLORIDE

DR RAMESH B.

PARMAR

14-Feb-19 172120820001 Bhanderi Brijesh Ashokbhai MRW403P 20 212 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS

DESIGN AND OPTIMIZATION OF LUTEIN

LOADED SOLID LIPID NANOPARTICLES FOR

OPTHALMIC DELIVERY

DR S R SHAH

14-Feb-19 172120820004 CHRISTIAN PRAJAL MUKESHBHAI MRW403P 20 212 MP Pharmaceutics MULTIPARTICULATE


LAFUTIDINE LIQUISOLID PELLETS FOR

ENHANCEMENT OF DISSOLUTION .

DR J S PAUN

14-Feb-19 172310820001 Balas Mayur Vashrambhai MRW403P 20 231 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS


NIOSOMAL GEL OF VORICONAZOLE FOR

SEVERE FUNGAL INFECTION

DR. SANDIP PATEL

14-Feb-19 172310820002 Garachar Dhaval Ranabhai MRW403P 20 231 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


OF ACARBOSE OSMOTIC TABLET

MR. SUMIT

CHAKRABORTY

14-Feb-19 172310820003 KALARIA VISHWA JITENDRABHAI MRW403P 20 231 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DESIGN AND EVALUATION OF INSITU GEL

EYE DROPS CONTAINING NANOPARTICLES

OF GEMIFLOXACIN MESYLATE

MR. SUMIT

CHAKRABORTY

14-Feb-19 172120820008 MAVANI CHINTAN PRAVINBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT


OF NOVEL CO-PROCESSED EXCIPIENT OF

TRICALCIUM CITRATE BY SPRAY DRYING.

DR R D PARMAR

14-Feb-19 172120820011PRAJAPATI RAVIRAJ

RAMESHKUMARMRW403P 20 212 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN AND EVALUATION OF

TRANSDERMAL PATCH CONTAINING

ANTIEMETIC DRUG

DR. J M PATEL

14-Feb-19 172120820012PRAJAPATI URVASHI

RAMESHBHAIMRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

PHYSICOCHEMICAL PROPERTY

IMPROVEMENT OF CEFPODOXIME

PROXETIL BY CO PROCESSING

DR. JAYANT R.

CHAVDA

14-Feb-19 172120820013SAKHIYA DHRUV

CHANDRAKANTBHAIMRW403P 20 212 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

PREPARATION AND EVALUTION OF

ITRACONAZOLE TOPICAL NANOGEL

DR C H

BORKHATARIYA

14-Feb-19 172120820014 SANGHANI DIVYABEN VINODBHAI MRW403P 20 212 MP Pharmaceutics

CO PROCESSED, DC,

TABLET/CAPSULE

EXCIPIENTS AND AT

AUGMENTATION OF PHYSICOCHEMICAL

PROPERTIES OF CEFUROXIME AXETIL BY

SPHERICAL AGGLOMERATION.

DR R D PARMAR

14-Feb-19 172120824001 Chavda Meghaben MRW403P 24 212 MPPharmaceutical




GENOTOXIC IMPURITIES IN RANOLAZINE

API BY GAS CHROMATOGRAPHY

DR. ASHOK B. PATEL

14-Feb-19 172120824003 DHADUK AKTABEN RAMESHBHAI MRW403P 24 212 MPPharmaceutical

Quality Assurance

QUALITY RISK

MANAGEMENT

QUALITY BY DESIGN APPROACH TO FIND

DESIGN SPACE IN THE DEVELOPMENT OF

RP-HPLC METHOD FOR ESTIMATION OF

AMITRIPTYLINE HYDROCHLORIDE BY

CENTRAL COMPOSITE DESIGN (CCD)

MR. AJAY I. PATEL

14-Feb-19 172630824001 PATEL SAPANA JOITARAM MRW403P 24 263 MPPharmaceutical

Quality Assurance

QUALITY RISK

MANAGEMENT

RP-HPLC METHOD FOR DETERMINATION

OF ADAPALENE USING CENTRAL

COMPOSITE DESIGN

DR. SHITAL FALDU

14-Feb-19 172120824002CHOUDHARY JYOTISHNA

BHOOPALSINGHMRW403P 24 212 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


VALIDATION FOR THE ESTIMATION OF

ARTEMETHER AND LUMEFANTRINE IN

MARKETED FORMULATION BY UPLC

DR. ASHOK B. PATEL

14-Feb-19 172120824010 MODH JAIVIK HITESHKUMAR MRW403P 24 212 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



DICLOFENAC DIETHYLAMINE TOPICAL

SOLUTION BY RP-HPLC METHOD

DR. NILESH K. PATEL

14-Feb-19 172120824012PATEL KRUPALIBEN

JAGADISHBHAIMRW403P 24 212 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


DAPAGLIFLOZIN PROPANEDIOL

MONOHYDRATE & METFORMIN HCL IN

BULK AND TABLET DOSAGE FORM USING

UPLC

DR.AMITKUMAR J

.VYAS

14-Feb-19 172120824013 PATEL RUPALBEN ASHOKBHAI MRW403P 24 212 MPPharmaceutical





AMLODIPINE BESYLATE AND CELECOXIB IN

SYNTHETIC MIXTURE BY RP-HPLC

DR. ASHOK B. PATEL

14-Feb-19 172120824006JETHAVA PALAKBEN

NANDLALBHAIMRW403P 24 212 MP

Pharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

EVALUATION OF INSTABILITY ISSUE IN

PAEDIATRIC DRY SYRUP OF

CEPHALOSPORIN ANTIBIOTIC IN

COMBINATION WITH CLAVULANIC ACID

DR. NILESH K. PATEL

14-Feb-19 172120824005 JANI SHIVANI NILESHKUMAR MRW403P 24 212 MPPharmaceutical


STUDY OF REGULATORY REQUIREMENTS

FOR PHARMACEUTICALS IN NON-

EUROPEAN UNION MEMBER STATES

KOSOVO, UKRAINE AND SERBIA

DR. NILESH K. PATEL

14-Feb-19 172120824007 KATESHIYA GOVIND AMRUTLAL MRW403P 24 212 MPPharmaceutical



AND VALIDATION FOR SIMULTANEOUS

ESTIMATION OF NAPROXEN AND

DIPHENHYDRAMINE IN K3EDTA HUMAN

PLASMA BY USING LC-ESI-MS/MS

MR. AJAY I. PATEL

14-Feb-19 172120824008KHATRI AKSHALIBEN

RAMCHANDRAMRW403P 24 212 MP

Pharmaceutical



AND VALIDATION FOR ESTIMATION OF

DOFETILIDE IN KȝEDTA HUMAN PLASMA BY

USING LC-ESI-MS/MS

MR. AJAY I. PATEL

14-Feb-19 172120824009 KULKARNI POOJA CHANDRAKANT MRW403P 24 212 MPPharmaceutical




DOSULEPIN HYDROCHLORIDE IN KʒEDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS

DR.AMITKUMAR J

.VYAS

14-Feb-19 172120824011 PARMAR ANKUR MOHANBHAI MRW403P 24 212 MPPharmaceutical




VARENICLINE TARTRATE USING KʒEDTA

HUMAN PLASMA BY LC-ESI-MS/MS

DR. ASHOK B. PATEL

14-Feb-19 172120824015SHARMA JIGNASHA

KRUSHNAKANTMRW403P 24 212 MP

Pharmaceutical




FLUCYTOSINE IN KȝEDTA HUMAN PLASMA

BY USING LC-ESI-MS/MS

DR.AMITKUMAR J

.VYAS

14-Feb-19 172020822001TARAPRA ANKITABEN

MOHANBHAIMRW403P 22 202 MP

Pharmaceutical

Chemistry

OTHER (KINDLY

SPECIFY)

DESIGN, SYNTHESIS AND ANTI-ALZHEIMER

ACTIVITY OF NOVEL CHROMAN

DERIVATIVES

DR. VIPUL VAGHELA

14-Feb-19 172280822001 BORANA VIPUL LAXMANBHAI MRW403P 22 228 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTIDIABETICS)

DESIGN, SYNTHESIS AND EVALUATION OF

SOME HETEROCYLCIC COMPOUNDS AS

ANTIDIABETIC AGENTS

DR. ANURADHA K

GAJJAR

14-Feb-19 172280822003 Harshita Bodha MRW403P 22 228 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

DESIGN, MOLECULAR MODELLING,

SYNTHESIS AND ANTI-INFLAMMATORY

ACTIVITY OF SOME SUBSTITUTED 5-

MEMBERED HETEROCYCLES

DR. BEENKUMAR R.

PRAJAPATI

14-Feb-19 172280822004 JAHA MIRAJ SANJAY MRW403P 22 228 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

DESIGN AND SYNTHESIS OF SOME NEW

BENZOXAZOLE DERIVATIVES AS ANTI-

OBESITY AGENTS

DR. DIPEN K. SUREJA

14-Feb-19 172280822002 Donga Hiren Ashokbhai MRW403P 22 228 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

NEW PYRROLO[2,3-D]PYRIMIDINE

DERIVATIVES AS POTENTIAL ANTICANCER

AGENTS: DESIGN, SYNTHESIS AND

BIOLOGICAL EVALUATION

DR. MAHESH T.

CHHABRIA

14-Feb-19 172280822005Prajapati Ravi kumar

GhanshyambhaiMRW403P 22 228 MP

Pharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

DESIGN, SYNTHESIS AND EVALUATION OF

SOME NEW SUBSTITUTED PYRIMIDINE

DERIVATIVES AS ANTICANCER AGENTS

DR. MAHESH T.

CHHABRIA

14-Feb-19 172540822001DHARASANDIYA ARZOO

PRABHUDASMRW403P 22 254 MP

Pharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW BRIDGEHEAD

NITROGEN HETEROCYCLES AS POTENTIAL

ANTICANCER AGENTS

DR. M. N. NOOLVI

14-Feb-19 172540822002 JOSHI NIDHIBEN BHASKARBHAI MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW QUINAZOLINE

DERIVATIVES AS ANTICANCER AGENTS

MS. MONIKA

KAKADIYA

14-Feb-19 172540822003 MOGAL AZMIN MAHERVAN MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW TAMOXIFEN

ANALOGUES AS POTENTIAL ANTICANCER

AGENTS

DR. M. N. NOOLVI

14-Feb-19 172540822005 PATEL ZOFINA IKBAL MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CANTHARIDIN


AGENTS

DR. M. N. NOOLVI

14-Feb-19 172540822009 Zalavadiya Vivek Sureshbhai MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

(ANTICANCER)

SYNTHESIS OF NEW CHROMAN-4-ONE


AGENTS

DR. M. N. NOOLVI

14-Feb-19 172540822004 PATEL SAMEERA SULEMAN MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

SYNTHESIS AND EVALUATION OF NEW 7-

HYDROXY COUMARIN DERIVATIVES AS

ANTI- ALZHEIMER AGENTS

DR. MORE UTTAM

14-Feb-19 172540822007Rahevar Vidhikumari

BhupeshkumarMRW403P 22 254 MP

Pharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

SYNTHESIS AND EVALUATION OF NEW

FLAVONOID DERIVATIVES AS ANTI-

ALZHEIMER AGENTS

DR. MORE UTTAM

14-Feb-19 172540822008 SINGH RAMIYA TILAKDHARI MRW403P 22 254 MPPharmaceutical

Chemistry

MEDICINAL

CHEMISTRY

SYNTHESIS OF NEW QUINOLINE

DERIVATIVES AS ANTITUBERCULAR AGENTS

MS. MONIKA

KAKADIYA

15-Feb-19 172390820004 CHIRAG NATUBHAI PATEL MRW403P 20 239 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN AND CHARACTERIZATION OF

TRANSDERMAL PATCH OF VENLAFAXINE

HYDROCHLORIDE

DR. HITESH DALVADI

15-Feb-19 172390820009 Patel Kinjal Ishwarbhai MRW403P 20 239 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

DESIGN & OPTIMIZATION OF INTRANASAL

DRUG DELIVERY(SPRAY) OF QUETIAPINE

FUMARATE

DR. HITESH DALVADI

15-Feb-19 172390820010 SIDDIKI DOLLY SAFIULREHMAN MRW403P 20 239 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


OPTIMIZATION OF MICROEMULSION

BASED HYDROGEL OF TOLNAFTATE

DR. HITESH DALVADI

15-Feb-19 172540820002 Gangat Asma Abdulsattar MRW403P 20 254 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

FABRICATION AND CHARACTERIZATION OF

LULICONAZOLE FILM-FORMING TOPICAL

SPRAY FOR THE TREATMENT OF FUNGAL

INFECTION

DR. BHAVESH

AKBARI

15-Feb-19 172650820001BARIA ROHANKUMAR

PANKAJKUMARMRW403P 20 265 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


EVALUATION OF MATRIX TABLETS OF

DARIFENACIN HYDROBROMIDE

MRS.ANKITA J.PATEL

15-Feb-19 172650820005 KANZARIA JALPA HASMUKHBHAI MRW403P 20 265 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


EVALUATION OF NASAL IN SITU GEL OF

ANTIEPILEPTIC DRUG

DR. ANURADHA

PRAJAPATI

15-Feb-19 172150820001 HITESH SANJAY BAKAS MRW403P 20 215 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND DEVELOPMENT OF

RAFT FORMING FLOATING DRUG DELIVERY

SYSTEM FOR DOMPERIDONE SUSTAIN

DRUG RELEASE

MR VINOD RAMANI

15-Feb-19 172150820002PARMAR HIRENKUMAR

NARANBHAIMRW403P 20 215 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

To Study the effect of hydro-alcoholic

media on drug release behavior of

extended release tablet containing

metoprolol

MR VINOD RAMANI

15-Feb-19 172150820004 YADAV AJAY CHHOTELAL MRW403P 20 215 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND DEVELOPMENT OF IN

SITU GEL CONTAINING LEVOFLOXACIN

LOADED LIPOSOME FOR PERIODONTITIS

MR. R. SENTHIL KUMAR

15-Feb-19 172390820002 BHANDARI RINAL HASMUKHRAI MRW403P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


OPTIMIZATION OF IN-SITU NASAL GEL OF

FROVATRIPTAN SUCCINATE

MR. TULARAM

BAROT

15-Feb-19 172390820005 HALPATI DARSHITA UMESH MRW403P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


NANOPARTICLE BASED IN-SITU GEL OF

LOTEPREDNOL ETABONATE

DR. HITESH DALVADI

15-Feb-19 172390820012 SINGH SHOBHA DESHRAJ MRW403P 20 239 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND DEVELOPMENT OF IN-

SITU GEL FOR OCULAR DRUG DELIVERY OF

TRAVOPROST

DR. KOMAL PARMAR

15-Feb-19 172650820008 PATEL MANSVIBEN SURESHBHAI MRW403P 20 265 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EVALUATION OF REPEAT ACTION DRUG

DELIVERY SYSTEM OF LUBIPROSTONE

MR. AJAY TALELE

15-Feb-19 172390820007 PATEL JENI RAMUBHAI MRW403P 20 239 MP Pharmaceutics MISCELANEOUSDEVELOPMENT, EVALUATION AND

OPTIMIZATION OF ORAL CEFIXIME JELLY

MR. TULARAM

BAROT

15-Feb-19 172390820011 SINGH PRAGATI SHESH MRW403P 20 239 MP Pharmaceutics MISCELANEOUS

DESIGN & EVALUATION OF DRY POWDER

INHALER OF ETHIONAMIDE FOR

PULMONARY DRUG

DR. HITESH DALVADI

15-Feb-19 172650820007 PATEL ARMY PRAKASHBHAI MRW403P 20 265 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



EVALUATION OF SUBLINGUAL TABLET

CONTAINING NISOLDIPINE

DR.ANURADHA

PRAJAPATI

15-Feb-19 172390820003CHAUHAN VRUTTIKUMARI

BANKIMSINHMRW403P 20 239 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS

DEVELOPMENT, EVALUATION AND

OPTIMIZATION OF OXICONAZOLE NITRATE

LOADED SOLID LIPID NANOPARTICLE BASED

GEL

MR. TULARAM

BAROT

15-Feb-19 172390820006 OZA KIRTIBAHEN MANISHKUMAR MRW403P 20 239 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS


OPTIMIZATION OF NANOSUSPENSION FOR

DISSOLUTION ENHANCEMENT OF ZOTEPINE

DR. KOMAL PARMAR

15-Feb-19 172390820008 PATEL JIGNESHBHAI UTTAMBHAI MRW403P 20 239 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS


NOVEL BIGEL TOPICAL DRUG DELIVERY OF

LULICONAZOLE

DR. KOMAL PARMAR

15-Feb-19 172540820001CHAUHAN RISHABH

HEMANTKUMARMRW403P 20 254 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS


GELATIN TREATED ACECLOFENAC LOADED

EUDRAGIT RS 100 NANOSUSPENSION FOR

OSTEOARTHRITIS TREATMENT

DR. MANISH GOYANI

15-Feb-19 172540820003VARADE SNEHALKUMARI

MADHUKARBHAIMRW403P 20 254 MP Pharmaceutics

OTHER (KINDLY

SPECIFY)


SPHERICAL AGGLOMERATES OF

LORATADINE TO IMPROVE DISSOLUTION

RATE AND MICROMERITIC PROPERTIES

DR. BHAVESH

AKBARI

15-Feb-19 172650820003HALPATI HEMANGINIBEN

AMRUTBHAIMRW403P 20 265 MP Pharmaceutics

NANO

SUSPENSION/EMULSIO


DDS


AZELAIC ACID EMULGEL FOR ACNE &

HYPERPIGMENTATION TREATMENT

MRS.ANKITA JAY

PATEL

15-Feb-19 152240808004 gabani pratikkumar babulal 940102 08 224 MP PHARMACEUTICS MISCELANEOUS


BILAYER TABLETS OF VALSARTAN &

AMLODIPINE

KINJAL SOLANKI

15-Feb-19 172390820001 BEHERA SHREEKANT SHIVRAM MRW403P 20 239 MP PharmaceuticsOTHER (KINDLY

SPECIFY)


POLYMERIC MICELLE FOR DISSOLUTION

ENHANCEMENT OF EXEMESTANE

DR. KOMAL PARMAR

15-Feb-19 172150824002 GUPTA VANDANA BARJENDRA MRW403P 24 215 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


VALIDATION FOR FLUPIRTINE MALEATE

AND TRAMADOL HYDROCHLORIDE IN

SYNTHETIC MIXTURE

DR. ZARNA DEDANIA

15-Feb-19 172150824003 KERIWALA TEJAL MANOJKUMAR MRW403P 24 215 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


SPECTROSCOPIC AND HPLC METHODS FOR

LULICONAZOLE AND BECLOMETHASONE

DIPROPIONATE IN COMBINED

PHARMACEUTICAL DOSAGE FORM.

DR. GHANSHYAM

SHANGHANI

15-Feb-19 172150824005SHAH ABHISHEKKUMAR


Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


SPECTROSCOPIC AND HPLC METHODS FOR

ZONISAMIDE AND CILOSTAZOL IN

SYNTHETIC MIXTURE.

DR. ZARNA DEDANIA

15-Feb-19 172390824001 BHANUSHALI PRIYA DEVJIBHAI MRW403P 24 239 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

SPECTROSCOPIC AND CHROMATOGRAPHIC

METHODS DEVELOPMENT FOR


CILNIDIPINE AND BISOPROLOL FUMARATE

IN COMBINED DOSAGE FORM

DR. ALISHA PATEL

15-Feb-19 172390824002 KAMLI ANKITA SHANTILAL MRW403P 24 239 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




CANDESARTAN CILEXETIL AND AMLODIPINE

BESYLATE IN SYNTHETIC MIXTURE

MADHURI HINGE

15-Feb-19 172390824003 KUMBHAR RIDDHI SHIVAJI MRW403P 24 239 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

ANALYTICAL METHODS DEVELOPMENT

AND VALIDATION FOR AMLODIPINE

BESYLATE AND CELECOXIB AND

EVALUATION OF AN ACTIVATED CARBON

BASED DEACTIVATION SYSTEM FOR

DISPOSAL OF DIFFERENT MEDICATIONS

DR. ALISHA PATEL

15-Feb-19 172150824001 CHISTI ZENAB MOHD MASOOD MRW403P 24 215 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

HPTLC method development and validation

of Naproxen Sodium and Esomeprazole

Magnesium Trihydrate in combined dosage

form.

DR. ZARNA DEDANIA

15-Feb-19 172150824004 PRAJAPATI RICHA ATULBHAI MRW403P 24 215 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)

QBD APPROACH TO HPLC METHOD


ESTIMATION OF FLUOXETINE

HYDROCHLORIDE AND OLANZAPINE IN

PHARMACEUTICAL DOSAGE FORM.

DR. ZARNA DEDANIA

15-Feb-19 172390824004 Madhumita Ghosh Chowdhury MRW403P 24 239 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



LIFITEGRAST IN SYNTHETIC MIXTURE

MADHURI HINGE

15-Feb-19 172540824001 ANCY MATHEW MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


AND VALIDATION FOR THE ESTIMATION OF

VORTIOXETINE AND ARIPIPRAZOLE IN

SYNTHETIC MIXTURE

DR. SURESH KUMAR

15-Feb-19 172540824002 Jangra Sandeepkumar Parasram MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



ESTIMATION OF MIRABEGRON AND

SOLIFENACIN SUCCINATE IN SYNTHETIC

MIXTURE

DR. SURESH KUMAR

15-Feb-19 172540824003 MAHIDA KAJAL RAKESHKUMAR MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



ESTIMATION OF DOXOFYLLINE AND

ERDOSTEINE IN SYNTHETIC MIXTURE

DR. SURESH KUMAR

15-Feb-19 172540824005 PATEL HINAL HARISHBHAI MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


VALIDATION OF SIMULTANEOUS

ESTIMATION OF PREGABALIN AND

MELOXICAM IN BINARY MIXTURE

MR. ROHAN BARSE

15-Feb-19 172540824006 VARACHHIYA HIRAL JASVANTSINH MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)



ESTIMATION OF ITOPRIDE HYDROCHLORIDE

AND OMEPRAZOLE IN SYNTHETIC MIXTURE

MR. ROHAN BARSE

15-Feb-19 172390824005 PATEL HETA AMRUTBHAI MRW403P 24 239 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




AMITRIPTYLINE HYDROCHLORIDE AND

PERPHENAZINE IN SYNTHETIC MIXTURE

MRS. MEGHA

ASHESH SHAH

15-Feb-19 172650824001BHADRA RINKALBEN

MAHESHBHAIMRW403P 24 265 MP

Pharmaceutical




PRIMIDONE IN K3EDTA HUMAN PLASMA


DR.SHAILESH LUHAR

15-Feb-19 172650824003 KHETIYA MEGHA MANOJBHAI MRW403P 24 265 MPPharmaceutical




PAROXETINE HYDROCHLORIDE IN K3EDTA

HUMAN PLASMA BY USING LC-ESI-MS/MS

DR. SACHIN

BHASKAR

NARKHEDE

15-Feb-19 172650824006 PRAJAPATI HIRAL ARVINDBHAI MRW403P 24 265 MPPharmaceutical




ATAZANAVIR IN K3EDTA HUMAN PLASMA


DR. CHIRAG DESAI

15-Feb-19 172650824007RATHOD SHEETAL

JAGDISHCHANDRAMRW403P 24 265 MP

Pharmaceutical




NINTEDANIB IN K3EDTA HUMAN PLASMA

BY USING LC-APCI-MS/MS

DR.SHAILESH LUHAR

15-Feb-19 172680824001PARMAR VIRANCHI

JITENDRASINHMRW403P 24 268 MP

Pharmaceutical




FOR ESTIMATION OF VORTIOXETINE

HYDROBROMIDE IN PHARMACEUTICAL

DOSAGE FORM.

MR. SAGARKUMAR

P. PATEL

15-Feb-19 172650824002 DHUMAL SHRADDHA SURESH MRW403P 24 265 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF HPTLC

METHOD FOR SIMULTANEOUS ESTIMATION

OF OFLOXACIN, CLOTRIMAZOLE AND

ORNIDAZOLE IN THEIR COMBINED DOSAGE

FORM

DR. DULENDRA P.

DAMAHE

15-Feb-19 172650824008 SINGH NEHA PRAMOD MRW403P 24 265 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF OFLOXACIN, ORNIDAZOLE

AND RACECADOTRIL IN PHARMACEUTICAL

DOSAGE FORM BY HPTLC

DR. DULENDRA P.

DAMAHE

15-Feb-19 172540824004 Mandloi Nikita Rampalsingh MRW403P 24 254 MPPharmaceutical

Quality Assurance

OTHER (KINDLY

SPECIFY)


AND ITS VALIDATION FOR THE ESTIMATION

OF TENELIGLIPTIN HYDROBROMIDE

HYDRATE AND GLIMEPIRIDE IN SYNTHETIC

MIXTURE

DR. SURESH KUMAR

16-Feb-19 172060820002MALAVIYA VIKASKUMAR

MADHUBHAIMRW403P 20 206 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EVALUATION OF ONDANSETRON HCL

EXTENDED RELEASE TABLET

DR. MITTAL

MAHESHWARI

16-Feb-19 172080820003 PATEL DHRUV JAYNESHKUMAR MRW403P 20 208 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION AND EVALUATION OF FIXED

DOSE GASTRO-RETENTIVE BILAYER TABLET

CONTAINING METFORMIN AS SUSTAINED

RELEASE AND SIMVASTATIN AS IMMEDIATE

RELEASE.

DR. UPENDRA L

PATEL

16-Feb-19 172280820001 BHAVSAR JAINI PANKAJKUMAR MRW403P 20 228 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EVALUATION OF CONTROLLED RELEASE

TABLET OF ANTIDIABETIC AGENT.

DR. YAMINI SHAH

16-Feb-19 172280820009 Shah Pahini Jigarbhai MRW403P 20 228 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

FORMULATION, OPTIMIZATION AND

EVALUATION OF CONTROLLED RELEASE

TABLETS OF LORCASERIN HYDROCHLORIDE

DR. MANISH P.

PATEL

16-Feb-19 172420820002 Parekh Aarti Jayprakash MRW403P 20 242 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT & EVALUATION OF GASTRO

RETENTIVE FLOATING TABLETS FOR ORAL

DRUG DELIVERY OF ENTACOPONE

DR DHAVAL J PATEL

16-Feb-19 172600820001 ANKIT SINGH KUSHWAH MRW403P 20 260 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU

DEVELOPMENT, OPTIMIZATION AND

EVALUATION OF EXTENDED RELEASE

TABLET OF PALIPERIDONE

DR. KUNAL N. PATEL

16-Feb-19 172620820002PARMAR MADHAVSINH

VIJAYBHAIMRW403P 20 262 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


OF MOUTH DISSOLVING TABLETS OF

VILAZODONE HCL FOR THE TREATMENT OF

DEPRESSION

PROF. RAVI V. PATEL

16-Feb-19 172620820004 PRAJAPATI RINKUBEN ASHOKBHAI MRW403P 20 262 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


GASTRORETENTIVE DRUG DELIVERY

SYSTEM OF SOFOSBUVIR

PROF. BHUMI RAVAL

16-Feb-19 172080820001 BHATT VIBHUTI DHIRENKUMAR MRW403P 20 208 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


STUDY ON DISSOLUTION ENHANCEMENT

OF EZETIMIBE

DR. DASHRATH

PATEL

16-Feb-19 172280820005 NAMIT GUPTA MRW403P 20 228 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


MOUTH DISSOLVING FILMS OF

NARATRIPTAN HYDROCHLORIDE

DR. MANISH P.

PATEL

16-Feb-19 172280820007 Patel Het Suryakantbhai MRW403P 20 228 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



EVALUATION OF ORAL DOSAGE FORM OF

AN ANTI-OSTEOPOROTIC AGENT

DR. PRAFUL

BHARADIA

16-Feb-19 172420820004 Patel Parth Laxmanbhai MRW403P 20 242 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



GASTRIC FLOATING TABLETS CONTAINING

CAPTOPRIL AND HYDROCHLOROTHIAZIDE

DR S.K.SHAH

16-Feb-19 172420820005 PATEL PRIYANK MUKESHBHAI MRW403P 20 242 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


FORMULATION AND IN-VITRO


BLONANSERIN USING LIQUISOLID

COMPACTS

DR SANJESH G RATHI

16-Feb-19 172600820004 PATEL KRUSHIKA JAGDISHKUMAR MRW403P 20 260 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



MOUTH DISSOLVING FILM OF

FEXOFENADINE HYDROCHLORIDE

DR. KUNAL N. PATEL

16-Feb-19 172620820005 SHAH AMIBEN MAHESHKUMAR MRW403P 20 262 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



OF FAST DISSOLVING TABLETS OF

LINAGLIPTIN- AN ANTI-DIABETIC AGENT

PROF. SURAJ R.

CHAUHAN

16-Feb-19 172620820006 SHUKLA ABHAYKUMAR SANTOSH MRW403P 20 262 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



ORAL DISINTEGRATING STRIPS OF

TENELIGLIPTIN FOR THE TREATMENT OF

TYPE II DIABETES

PROF. RAVI V. PATEL

16-Feb-19 172080820002 DHRU KHUSHALI DARSHAKBHAI MRW403P 20 208 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


INTRANASAL DRUG DELIVERY OF

DIAZEPAM FOR STATUS EPILEPTICUS.

DR. DASHRATH

PATEL

16-Feb-19 172080820004 RUPARELIYA KETA SHAILESHBHAI MRW403P 20 208 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL

NASAL INSITU GEL OF ANTI-HIV DRUG FOR

NOSE TO BRAIN DRUG DELIVERY.

DR. SUNITA

CHAUDHARY

16-Feb-19 172280820003 JAHNAVI BHARGAV JANI MRW403P 20 228 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


EVALUATION OF TOPICAL PREPARATION OF

LUTEIN

DR. PRAFUL

BHARADIA

16-Feb-19 172280820004 MANAN VISHNUBHAI PATEL MRW403P 20 228 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


ORAL TRANSMUCOSAL DELIVERY SYSTEM

OF AN ANTI-MIGRAINE AGENT

DR. RADHIKA

PANDYA

16-Feb-19 172280820006 PATEL GRUSHA SANJAYKUMAR MRW403P 20 228 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


EVALUATION OF SPIRONOLECTONE GEL

FOR TREATMENT OF ANDROGENIC

ALOPECIA

DR. PRAFUL

BHARADIA

16-Feb-19 172420820007 SHAH JIGAR PRADIPKUMAR MRW403P 20 242 MP Pharmaceutics

DELAYED/EXTENDED

RELEASE, FLOATING,

INSITU


EVALUATION OF FLOATING TABLETS OF

APREMILAST

DR DHAVAL J.PATEL

16-Feb-19 172620820001 BACHANI KOMAL KANAIYALAL MRW403P 20 262 MP Pharmaceutics

BUCO/MUCOADHESIV

E, TDDS, TOPICAL,

HYDROGELS NASAL


TRANSDERMAL PATCHES OF ADEFOVIR

DIPIVOXIL FOR THE TREATMENT OF

HEPATITIS B

PROF. BHUMI RAVAL

16-Feb-19 172060820001 Gokani Preet Nitinkumar MRW403P 20 206 MP Pharmaceutics MISCELANEOUS


EVALUATION OF ACECLOFENAC LOADED

EMULGEL

DR. MITTAL

MAHESHWARI

16-Feb-19 172060820003 Swati Adhikari MRW403P 20 206 MP Pharmaceutics MISCELANEOUSIMPACT OF HOLD TIME ON PHYSICAL

PARAMETERS OF DRUG PRODUCT

DR. MITTAL

MAHESHWARI

16-Feb-19 172280820002 DESHMUKH GAURI NITEEN MRW403P 20 228 MP PharmaceuticsOTHER (KINDLY

SPECIFY)


EVALUATION OF SOLID ORAL DOSAGE

FORM OF PAROXETINE MESYLATE

DR. PRAFUL

BHARADIA

16-Feb-19 172280820008 ROMANSHA ANIL BERI MRW403P 20 228 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST



EVALUATION OF SUBLINGUAL TABLETS OF

AN ANTI-PSYCHOTIC DRUG

DR. YAMINI SHAH

16-Feb-19 172280820010 SOLANKI SNEHABEN BALDEVBHAI MRW403P 20 228 MP PharmaceuticsOTHER (KINDLY

SPECIFY)

PAEDIATRIC FORMULATION OF CEFIXIME

TRIHYDRATE AND ITS EVALUATIONDR. YAMINI SHAH

16-Feb-19 172420820001 GOSWAMI ASAV NARENDRAPURI MRW403P 20 242 MP Pharmaceutics

IR, ODT, DT,

SUBLINGUAL, FAST


PHYSICOCHEMICAL CHARACTERIZATION

AND IN-VITRO DISSOLUTION

ENHANCEMENT OF RANOLAZINE USING

SOLID DISPERSION METHOD

DR S.K.SHAH

16-Feb-19 172060824001 CHAUHAN SUDIKSHA RAMKUMAR MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING RP-UPLC METHOD

DEVELOPEMENT AND VALIDATION FOR

SIMULTANEOUS ESTIMATION OF ASPIRIN,

ROSUVASTATIN CALCIUM AND

CLOPIDOGREL BISULPHATE IN TABLET

DR. NEHA TIWARI

16-Feb-19 172060824006 PATEL DIPALIBEN JAYANTIBHAI MRW403P 24 206 MPPharmaceutical


STABILITY INDICATING RP-UPLC METHOD

DEVELOPEMENT AND VALIDATION FOR

OLMESARTAN MEDOXOMIL,

CHLORTHALIDONE AND CLINIDIPINE IN

THEIR COMBINED TABLET DOSAGE FORM

DR. NEHA TIWARI

16-Feb-19 172080824001 PANCHAL URVISHA GOVINDBHAI MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING HPTLC METHOD


DACLATASVIR DIHYDROCHLORIDE IN


DR. RAGIN SHAH

16-Feb-19 172080824004 PATEL NIDHIBEN VINODBHAI MRW403P 24 208 MPPharmaceutical




DOFETILIDE IN CAPSULE DOSAGE FORM

DR NISHA PARIKH

16-Feb-19 172080824006 SHAH CHARMI RAJESH MRW403P 24 208 MPPharmaceutical





ILAPRAZOLE AND LEVOSULPRIDE IN


MS JIGNASHA

DERASARI

16-Feb-19 172240824001CHAUDHARY RAJESHBHAI

BHIKHABHAIMRW403P 24 224 MP

Pharmaceutical





SERTACONAZOLE NITRATE AND

BECLOMETHASONE DIPROPIONATE IN ITS


DR. HIRAL PANCHAL

16-Feb-19 172240824002 DAMSIYA NIKHIL KARSHANBHAI MRW403P 24 224 MPPharmaceutical






CHLORTHALIDONE IN ITS


DR. HIRAL PANCHAL

16-Feb-19 172060824002 Dodiya Karan sinh Vajesangbhai MRW403P 24 206 MPPharmaceutical





DIAZEPAM AND DICYCLOMINE IN THEIR

COMBINED TABLET

DR. PRAGNESH

PATANI

16-Feb-19 172060824003 GUPTA MONIKA HARERAM MRW403P 24 206 MPPharmaceutical


DEVELOPEMENT AND VALIDATION OF



DOXOFYLLINE AND ACEBROPHYLLINE IN

THEIR COMBINE DOSAGE FORM

DR.PRAGNESH

PATANI

16-Feb-19 172060824004 MUDALIAR REVATI GANESHBHAI MRW403P 24 206 MPPharmaceutical



STABILITY INDICATING ASSAY RP-HPLC

METHOD FOR THE SIMULTANEOUS

ESTIMATION OF DICYCLOMINE AND

SIMETHICONE IN ITS PHARMACEUTICAL

DOSAGE FORM

DR. PRAGNESH

PATANI

16-Feb-19 172060824012VAGHELA YAVANTIKA

VIRENDRASINHMRW403P 24 206 MP

Pharmaceutical




FOR THE ESTIMATION OF DAPAGLIFLOZIN

IN ITS TABLET DOSAGE FORM

DR. PRAGNESH

PATANI

16-Feb-19 172420824005 SUDHIRKUMAR GAMI MRW403P 24 242 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

RP-HPLC METHOD DEVELOPMENT AND


ESTIMATION OF BENIDIPINE

HYDROCHLORIDE, TELMISARTAN AND


DR. ANKIT B.

CHAUDHARY

16-Feb-19 172600824002KIRAD AASHUTOSHSINH

RAMNATHMRW403P 24 260 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


FOR FOR SIMULTANEOUS ESTIMATION OF

ATORVASTATIN AND SITAGLIPTIN

PHOSPHATE IN SYNTHETIC MIXTURE

MS. NIKITA A. PATEL

16-Feb-19 172280824001CHAUHAN KEYURKUMAR

RAMESHBHAIMRW403P 24 228 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


SPECTROPHOTOMETRIC AND

CHROMATOGRAPHIC METHODS FOR



TELMISARTAN IN THEIR COMBINED

DOSAGE FORM

DR. KUNJAN

BODIWALA

16-Feb-19 172280824004 MODI PINAL SATISHKUMAR MRW403P 24 228 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




NEBIVOLOL HYDROCHLORIDE AND

TELMISARTAN IN THEIR COMBINED

DOSAGE FORM

DR. SINDHU EZHAVA

16-Feb-19 172420824006SUTHAR NISHABEN

JAYESHKUMARMRW403P 24 242 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



SIMULTANEOUS ESTIMATION OF ORLISTAT

AND RESVERATROL IN CAPSULE

MS. CHARMY D.

PANDYA

16-Feb-19 172620824001 BASITA NIKHIL CHAMPAKBHAI MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND VILDAGLIPTIN IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824002 DAVE MANSIBEN SHIRISHKUMAR MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF LOSARTAN POTASSIUM

AND ROSUVASTATIN CALCIUM IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824005 PARTH SHAKARABHAI PATEL MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF PIOGLITAZONE

HYDROCHLORIDE AND NATEGLINIDE IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824009 PATEL HIRAL ASHOKBHAI MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF RAMIPRIL AND

SIMVASTATIN IN SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824011 SONARA KAJAL HARIBHAI MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF REPAGLINIDE AND

SITAGLIPTIN PHOSPHATE IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172060824005PATEL BHARGAVKUMAR

PRADIPBHAIMRW403P 24 206 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


VALIDATION OF THE SIMULTANEOUS

ESTIMATION OF

TRIHEXYPHENIDYL,TRIFLUOPERAZINE AND

THIORIDAZINE IN ITS PHARMACEUTICAL

DOSAGE FORM BY HPLC METHOD

MRS.VANITA

MARVANIYA

16-Feb-19 172280824005 Patel Nidhi Tikendrabhai MRW403P 24 228 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION




OFLOXACIN, TINIDAZOLE, TERBINAFINE

HYDROCHLORIDE AND CLOBETASOL

PROPIONATE IN TOPICAL FORMULATION

DR. KUNJAN

BODIWALA

16-Feb-19 172280824008SHARMA PRIYANKA

KAMLESHBHAIMRW403P 24 228 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION

DEVELOPMENT AND VALIDATION OF A

STABILITY INDICATING HPTLC METHOD FOR

TENELIGLIPTIN AND METFORMIN.

DR. MAHESH T.

CHHABRIA

16-Feb-19 172620824003 HIMANI RAJESHKUMAR SAVANI MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF SIMVASTATIN AND

PIOGLITAZONE HYDROCHLORIDE IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824004MOURYA POONAM

GHANSHYAMBHAIMRW403P 24 262 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF LISINOPRIL AND

LOSARTAN POTASSIUM IN SYNTHETIC

MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172620824008 PATEL DIVYABEN VIRCHANDBHAI MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION


OF LEVODOPA AND BENSERAZIDE IN ORAL

DISPERSIBLE TABLET BY RP-HPLC METHOD

DR JITENDRA O.

BHANGALE

16-Feb-19 172620824010 Saini Ravi bhanwarlal MRW403P 24 262 MPPharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF VILDAGLIPTIN AND

NATEGLINIDE IN SYNTHETIC MIXTURE

DR JITENDRA O.

BHANGALE

16-Feb-19 172620824012TRIVEDI FORAM

DHARMENDRABHAIMRW403P 24 262 MP

Pharmaceutical

Quality Assurance

SIMULTENEOUS

ESTIMATION



ESTIMATION OF NEBIVOLOL

HYDROCHLORIDE AND LISINOPRIL IN

SYNTHETIC MIXTURE

DR. JITENDRA O.

BHANGALE

16-Feb-19 172060824007 PATEL YASH KANUBHAI MRW403P 24 206 MPPharmaceutical




FORMOTEROL IN HUMAN PLASMA BY LC-

MS/MS.

MRS.VANITA

MARVANIYA

16-Feb-19 172600824001BAMBHROLIYA VIREN

GHANSHYAMBHAIMRW403P 24 260 MP

Pharmaceutical




FLUTICASONE IN HUMAN PLASMA BY LC-

MS/MS

DR. CHIRAG J. PATEL

16-Feb-19 172620824006 PATEL BINAL NARESHBHAI MRW403P 24 262 MPPharmaceutical



VALIDATION FOR IMPURITY PROFILE OF

CITICOLINE SODIUM IN TABLET DOSAGE

FORM

DR. JITENDRA O.

BHANGALE

16-Feb-19 172860824001 kunal Bhatt MRW403P 24 286 MPPharmaceutical



BIOANALYTICAL METHOD FOR

DETERMINATION OF CLOMIPRAMINE

FROM K3 EDTA HUMAN PLASMA USING LC-

MS/MS.

DR. MANDEV B.

PATEL

16-Feb-19 172860824002Kuntalkumar maheshbhai

prajapatiMRW403P 24 286 MP

Pharmaceutical




DETERMINATION OF AMBRISENTAN FROM

K3 EDTA HUMAN PLASMA USING LC-

MS/MS.

DR. MANDEV B.

PATEL

16-Feb-19 172860824007 Prajapati Kinnari Dasharathbhai MRW403P 24 286 MPPharmaceutical



BIOANALYTICAL MEHTHOD FOR

DETERMINATION OF DEFERASIROX FROM

HUMAN PLASMA USING LC-MS/MS.

MS. MINAKSHI

DHORU

16-Feb-19 172860824009 Shah Kajal Rajendrabhai MRW403P 24 286 MPPharmaceutical




DETERMINATION OF EXEMESTANE FROM


MS/MS

MS. MINAKSHI

DHORU

16-Feb-19 172860824014 vikas pal MRW403P 24 286 MPPharmaceutical




DETERMINATION OF PROPAFENONE FROM


MS/MS

DR. MANDEV B.

PATEL

16-Feb-19 172060824011 VAGHELA AKSHAY PRAVINBHAI MRW403P 24 206 MPPharmaceutical




SIMULTANEOUS DETERMINATION OF

IBUPROFEN AND HYDROCODONE

BITARTRATE IN THEIR COMBINED DOSAGE

FORM

DR. NEHA TIWARI

16-Feb-19 172080824002 PARMAR MONIKA JAGDISHBHAI MRW403P 24 208 MPPharmaceutical



DEVELOPMENT AND VALIDATION OF S(-)

AMLODIPINE BESYLATE AND

HYDROCHLOROTHIAZIDE IN BULK AND


MR HIREN KADIKAR

16-Feb-19 172080824003 PATEL BHOOMIKA VINODBHAI MRW403P 24 208 MPPharmaceutical




DOLUTEGRAVIR, LAMIVUDINE AND

TENOFOVIR DISOPROXIL FUMARATE IN ITS


MS MONA KAUSHAL

16-Feb-19 172080824005 SAIYAD ANISH MIRSHABMIYA MRW403P 24 208 MPPharmaceutical


STABILITY INDICATING METHOD



EMTRICITABINE AND TENOFOVIR

ALAFENAMIDE IN TABLET DOSAGE FORM

DR JITENDRA PATEL

16-Feb-19 172600824004 PANCHAL SHIVANI HITESHKUMAR MRW403P 24 260 MPPharmaceutical




ESTIMATION OF TOFACITINIB IN

TOFACITINIB CITRATE IMMEDIATE RELEASE

TABLET DOSAGE FORM

DR. CHIRAG J. PATEL

16-Feb-19 172600824006 PATEL DIMPLE NATVARLAL MRW403P 24 260 MPPharmaceutical



BY CHROMATOGRAPHIC METHOD FOR

DETERMINATION OF ERYTHROMYCIN IN


DR. CHIRAG J. PATEL

16-Feb-19 172860824003MAKWANA HEMANGIBEN

SHASHIKANTMRW403P 24 286 MP

Pharmaceutical




FOR DETERMINATION OF EFONIDIPINE

HYDROCHLORIDE ETHANOLATE IN BULK

AND TABLET DOSAGE FORM.

MRS. BINNY D.

MEHTA

16-Feb-19 172860824008 sangale Hemangi Shivji MRW403P 24 286 MPPharmaceutical



STABILITY INDICATING RP HPLC METHOD

FOR DETERMINATION OF MIRABEGRON

FROM ITS PHARMACEUTICAL

FORMULATION

MRS. BINNY D.

MEHTA

16-Feb-19 142240808014 Vyas Marmik Ashokbhai 940102 8 224 MP PHARMACEUTICS


SUSTAINED RELEASE TABLETS OF

BUSPIRONE HYDROCHLORIDE

MR.JAYANTI BAJAG

Sd/-

I/C Contoller of Examination

gujarat technological university student list for m.pharm sem 4 … · 11-feb-19 172050825008 singh...

Documents